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Branching morphogenesis is a common mechanism of mammalian development.
Branched epithelia of kidneys, lungs, mammary glands etc develop from an
initially unbranched epithelial bud which develops under the control of
reciprocal interactions between the growing epithelium and the mesenchyme that
surrounds it. To examine how morphogenetic signals change the shape of the
epithelium this thesis examines the urinary collecting duct as a model for
branching and tests the hypothesis that the tips of the epithelium are specialized
for morphogenesis.
Kidney development begins when the ureteric bud, an outgrowth of the Wolffian
duct, invades the metanephric mesenchyme. This then induces the bud to grow
and bifurcate repeatedly to form the collecting duct system. To better understand
how the ureteric bud tips are specialized to produce branches, this thesis
compares their cell biology to that of the rest of the ureteric bud using the murine
metanephric organ culture as a model system. Specifically, it describes the
pattern of cell proliferation, cytoskeletal organization as assessed by
immunofluorescence and confocal laser scanning microscopy, glycoconjugate
expression in the tips and in the rest of the bud by means of lectin histochemistry
and gene expression by differential display PCR.
Increased cell proliferation, measured by bromodeoxyuridine incorporation, is
found at the tips of the branching epithelium. This pattern of increased cell
proliferation correlates with branching activity and is lost when branching is
arrested in kidney rudiments depleted of sulphated glycosaminoglycans. Known
mediators of ureteric bud branching in culture such as GDNF and TGF-p were
examined for their effect on cell proliferation at the ureteric bud tips; TGF-P
reduced proliferation and GDNF either increased it or had no effect, depending
on whether it was applied locally or generally.
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Microfilaments, detected by fluorescent-tagged phalloidin, are strongly
expressed in the apical parts of the ureteric bud tips during branching. Inhibition
of branching (either by depletion of sulphated glycosaminoglycans or by a MAP
kinase inhibitor) disrupts this localized expression. Cytochalasin D disruption of
filamentous actin inhibits branching, results in cell scattering from the ureteric
bud tips and alters the cell junctions as revealed by E-cadherin distribution.
Actomyosin interactions also regulate branching of the ureteric epithelium as
shown by a general myosin inhibitor.
Expression of lectin binding glycoconjugates at the ureteric bud tips differs from
the stalks. Dolichos Biflorus Agglutinin (DBA), a known collecting duct marker,
is found to selectively binding to stalks. This binding pattern is present during
active branching but is lost when branching is blocked. Organ recombination
experiments show that the ureteric bud stalk cells are able to generate DBA-
negative tip cells upon amputation and regeneration. Finally, genes expressed
differentially between ureteric bud tips and stalks provide further evidence to
support the hypothesis that the tubule tips are specialized structures.
11
Chapter 1
An Introduction to Early Kidney Development
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1.1 Kidney development on kidney disease
Clinically significant abnormalities of kidney development affect 10 percent of
the population (Potter, 1972). Developmental anomalies of the kidney fall into
two main groups. There are those related to the complete organ, which include
changes in the size, shape, location or number of the organ and those related to
individual parts of the organ such as changes in the collecting tubules, nephrons
or stroma (Potter, 1972). There are also numerous syndromes with a renal
phenotype, such as the Von Hippel-Lindau syndrome and Kallmann's syndrome
(Stephens et al., 1996).
Ureteric branching morphogenesis is a key event in the development of the
collecting duct system of the permanent kidney. The branching pattern of the
collecting duct epithelium largely defines the final histoarchitecture of the
kidney. Abnormalities in branching morphogenesis can lead to abnormalities in
renal structure and function. Defective branching morphogenesis and growth of
the collecting duct are likely to reduce the number of nephrons produced during
kidney development, as newly formed nephrons arise at the tips of the branches
of the ureteric epithelium. Inherited or acquired reduction in number of nephrons
is associated with an increased risk of developing hypertension and chronic renal
failure.
Renal dysplasias are morphologically heterogeneous and of variable aetiology.
Many congenital cystic kidney disorders are caused by defective morphogenesis
of the ureteric bud and abnormal development of the collecting duct system.
Infantile (autosomal recessive) polycystic kidney disease is characterized
pathologically by enlarged reniform kidneys with very numerous, fine, elongated
collecting ducts radiating from pelvis to the cortex (described in Stephens et al.,
1996). Multicystic dysplastic kidneys may have either a characteristic grape-like
appearance or small microcysts and some minicysts. Only a few generations of
collecting ducts are produced. The lumens are increased in diameter and many
terminate in cysts. Dysplasia of the nephrons and stroma is present, along with a
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reduction in nephron endowment (Potter, 1972; Stephens et al., 1996). Cases of
unilateral or bilateral kidney agenesis are associated with total absence of the
ureter which is caused by absence of the lower portion of the mesonephric duct
or by failure of the duct to give rise to the ureteric epithelium (Potter, 1972).
Research on genes and other molecules that are required for normal development
of the collecting duct may help towards an understanding of the causes of the
congenital renal abnormalities. The research evidence presented in this thesis
focuses on intrinsic mechanisms during the early stages of the collecting duct
development.
The paragraphs that follow introduce kidney development focusing on ureteric
bud branching morphogenesis that gives rise to the collecting duct system and on
key regulators that have been found to play a significant role in the process.
1.2 Organogenesis of the permanent kidney
During embryogenesis, the developing kidney forms in three distinct stages. The
mammalian permanent kidney (metanephros) follows the appearance and
subsequent degeneration of two transient and primitive structures, the
pronephros and the mesonephros. All three structures develop along the nephric
duct (or Wolffian duct) as it grows caudally and reaches the cloaca (figure 1.1).
In the present thesis the term Wolffian duct will be used to describe the nephric
duct from the region of the mesonephros caudally.
The renal system derives from the intermediate mesoderm whereas the bladder
and urethra are of endodermal origin. The intermediate mesoderm consists of a
longitudinal ridge of cells just lateral to the paraxial mesoderm of the somites
that run from the cervical through to the caudal regions of the embryo (for a
review, see Sakurai and Nigam, 2000). The first epithelial tubule to differentiate
















Figure 1.1: The three major stages of mammalian kidney
development
(A) The pronephric tubules are induced from the nephrogenic
mesenchyme by the pronephric duct as it migrates caudally, (B) as
the pronephros degenerates the mesonephric tubules are formed. (C)
the final mammalian kidney, the metanephros, is induced by the
ureteric bud. (From Gilbert, 1997).
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of the functional pronephros and mesonephros. It also organizes the
metanephros and contributes to the male genital system (Saxen, 1987).
In the human embryo the pronephros (figure 1.2) is visible in the intermediate
mesoderm of the 10-somite embryo between the second and sixth somite (Potter,
1972). It consists of a few epithelial tubular structures variably connected to the
pronephric duct (Sakurai and Nigam, 2000). This temporary organ is non¬
functional and degenerates shortly after its appearance, by the 20 somite stage
(Potter, 1972). In mice, the pronephros appears at embryonic day 8 (E8).
Glomerulus-like structures are present but do not appear to be physically
connected to the tubules (Sakurai and Nigam, 2000). Even though the pronephros
has no function in mammals, it is functional and essential for survival in fish and
amphibian larvae (Saxen, 1987). The pronephroi of fish and amphibia typically
contain 1 to 3 nephrons. The amphibian pronephros is a simple structure
composed of three principle parts: the pronephric corpuscle, the pronephric
tubules and the pronephric duct. The corpuscle consists of the pronephric capsule
and a vascular component, the glomus. The pronephric tubules are composed of
three segments; ciliated nephrostomes, connecting tubules and a common tubule
(Brandli, 1999). The pronephros undergoes regression and apoptosis and its
function is replaced by the mesonephros which in lower vertebrates is the
permanent kidney of the adult organism (Brandli, 1999; Vize et al., 1997).
Soon after/during pronephric degeneration, the mesonephric kidney appears
along the Wolffian duct. The mesonephros (figure 1.2) is a less complex kidney
found in embryos of higher vertebrates. In mammals, the mesonephros later
degenerates and is followed by the development of metanephros. Its basic
structure is similar to that found in metanephros. It consists of glomeruli with a
well-developed vasculature, proximal and distal tubules and collecting ducts but
no loops of Henle. The glomeruli of the mesonephros are relatively large in
comparison to the glomeruli of the metanephros but they are fewer (Moritz and











(Picture credit P. Vize, from http://biology.kenyon.edu/courses)
Figure 1.2: Anatomy of pronephros and mesonephros
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basic types (Vize et al., 1997). One set is a cranial outgrowth of the Wolffian
duct whereas the other is caudal and not fused to the duct. In humans and pigs,
the mesonephros is a primitive functional secretory organ whereas in mice is non
functional (Sainio et al., 1997a). In human embryos, the mesonephros appears by
gestational day 24 and in mice at E9.5. It then regresses (by E15 in mice) in
females whereas in males becomes part of the reproductive tract including the
vas deferens and the cranial tubules will become the epididymal ducts (Sakurai
and Nigam, 2000).
In mammals, just before the Wolffian duct reaches the cloaca, the permanent
kidney (metanephros) develops (figure 1.3). In human embryos this occurs on
day 28 and in mice at Ell. The metanephros develops when an epithelial
evagination (called the ureteric bud) from the Wolffian duct grows into an area
of condensed mesenchyme, the metanephric or nephrogenic mesenchyme. From
this point forward the metanephros will develop through epithelial-mesenchymal
reciprocal interactions. The metanephric mesenchyme signals to the epithelial
bud, which as a result will grow and bifurcate in a process called branching
morphogenesis, and will give rise to the collecting duct system of the kidney.
The signals and signaling pathways that regulate the branching of the collecting
duct tree will be introduced in section 1.4.3. The branching ureteric bud in turn
signals to the metanephric mesenchyme, which has two fates: it will form the
stroma and the nephrons through a mesenchyme-to-epithelial transition (MET)
(reviewed in Davies, 1996).
Kidney nephrogenesis and vascularization are simultaneous and coordinated
processes. Nephron formation begins with the aggregation of mesenchymal
condensates around the tips of the ureteric bud branches, it is followed by the
epithelialization of these mesenchymal cells, vesicle formation, comma shape
and S-shape bodies formation and subsequent fusion with the ureteric bud
(reviewed in Davies, 1993; Davies and Bard, 1998; Horster et al., 1999) (figure




body capsule of Endothelial
glomerulus cells
(From Gilbert, 1997)
Figure 1.3: Development of metanephros
Reciprocal induction in the development of the mammalian
kidney. The ureteric bud enters the metanephric mesenchyme
which then induces the bud to branch. At the tips of the
branches, the epithelium induces the mesenchyme to
aggregate to form the renal tubules. The formation of the
nephron from mesenchyme is shown in the insert.
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d) S-shape body e) migration of
endothelial cells
f) glomerulogenesis
Figure 1.4: Stages of nephrogenesis during kidney
development
(a) The metanephric mesenchyme forms a condensate around the
ureteric bud tip. (b) the ureteric bud secretes signals that induce
formation of mesenchymal pretubular cell aggregates, which are
precursors of the nephrons, (c) induced tubules undergo mesenchymal-
to epithelial transition via comma-shaped and (d) S-shaped bodies and
subsequent fusion to the collecting duct, (e) the epithelializing body
expresses angiogenic factors that attract ingrowth of endothelial cells
into the developing nephron, (f) glomerulogenesis follows. (From
Kuure et al., 2000, adapted from Saxen, 1987).
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the other elongates and differentiates to form the proximal and distal convoluted
tubules and loop of Henle (Davies, 1993). Each nephron is composed of a
filtering glomerulus and a segmented epithelial tube. The glomerulus is formed
by interaction of Bowman's capsule with a capillary. The development of kidney
vasculature is still under debate. It is probably formed in situ (vasculogenesis)
from stem cells of the metanephric mesenchyme migrating into the vascular cleft
of the developing glomerulus and from the ingrowth of tube-like angiogenic
sprouts derived from external vessels (angiogenesis) (Abrahamson et al., 1998;
Saxen, 1987).
Nephron formation in human embryos occurs between gestational week 28 and
continues as late as the 36th week (Sakurai and Nigam, 2000). In mice,
nephrogenesis starts at El5 and continues in the postnatal period. Nephron
number varies between approximately 500,000 to 1,000,000 in humans and
reaches approximately 12,000 in mice (Vainio and Lin, 2002). The number of
nephrons produced (nephron endowment) depends on the branching of the
ureteric bud.
1.3 Models used to study branching morphogenesis
The mature adult kidney is a complex organ but the embryonic kidney is a
relatively simple organ. Classical experiments in the 1950s by Grobstein
established: (i) that the embryonic metanephros will develop in culture, (ii) that
after the mechanical separation of the two cell type components (epithelium and
mesenchyme) the epithelium undergoes morphogenesis in the presence of
homologous tissue (its own mesenchyme) recombination but not in the presence
of heterologous mesenchyme such as submandibular mesenchyme (the terms
'homogeneous combination' and 'heterogeneous combination' were used by
Grobstein), (iii) that the metanephric mesenchyme is required for proper ureteric
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growth and (iv) the transfilter technique (Grobstein, 1953a; Grobstein, 1953b;
Saxen, 1987).
Several kinds ofmodel systems have been established and the evidence available
to date on kidney development is a result of their extensive use. The in vitro
models to study branching morphogenesis include the classical organ culture
established by Grobstein and improved by Saxen (Saxen, 1987) and the three-
dimensional tubulogenic cell culture models.
1.3.1 Metanephric organ culture
Metanephric organ culture has been extensively used to study the various aspects
of metanephric development including branching morphogenesis (described in
Saxen, 1987). As this is the model used in this thesis, I am going to introduce it
in more detail than the other models. Whole kidney rudiments are isolated from
mice or rats at the stage of ureteric bud outgrowth from the Wolffian duct. They
are placed on a piece of polycarbonate Millipore filter, which is transferred to a
Trowell-type screen of stainless steel. The screen is placed in a simple petri dish
and culture medium is added to the level of the surface of the screen. The
medium consists of Eagle's basal medium in Earle's balanced salt solution
supplemented with 10% foetal calf serum. Due to the surface tension, the tissue
is covered with a thin layer of medium and the kidney rudiments become flat.
Organ cultures are placed in an incubator with an atmosphere of 5% CO2 in air.
The 11-day metanephric anlagen survive well in culture for up to 12 days and
ureteric bud branching and nephrogenesis take place. However, the organ is
avascular. The advantage of this technique is that organ culture in conjunction
with the use of advanced microscopy (confocal laser scanning microscopy)
allows the development of the branching epithelium to be observed in whole
mounts. The limitation of the technique however is the presence of both cell type
components of the metanephric kidney.
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1.3.2 Three-dimensional cell culture
Two kidney derived cell lines are commonly used for the production of three-
dimensional tubulogenesis models; the mouse inner medullary collecting duct-3
(mIMCD-3) cell line and the Madin-Darby canine kidney (MDCK) epithelial
cells. These cell lines when suspended in an extracellular matrix (ECM) gel
(either type I collagen or collagen-Matrigel mixture) form tubules that undergo
branching morphogenesis. MDCK cells growing in three-dimensional type I
collagen substrate form spherical cysts that extend tubular extensions within the
collagen matrix when treated with hepatocyte growth factor (HGF) (Montesano
et al., 1991a; Montesano et al., 1991b); reviewed in (Balkovetz, 1998). The
presence of the epithelial component alone make these three-dimensional
tubulogenesis cell lines good models for identification of possible positive or
negative factors responsible for branching. The limitation of these models is that
the branching pattern differs from that observed during metanephric development
making difficult to assess the effect of the regulatory signals on the branching
architecture.
1.3.3 Isolated ureteric bud culture
Another model has recently been established where isolated ureteric bud cells are
grown in culture in the absence of mesenchymal contact (Qiao et al., 1999a). In
this model the ureteric bud cells are cultured in a mixture of type I collagen and
growth depleted-Matrigel. After the addition of a mixture of growth factors and
pleiotrophin, dichotomous branching-morphogenesis resembling the structures of
the developing kidney is achieved (Qiao et al., 1999a; Sakurai et al., 1997;
Sakurai et al., 2001). The advantage of this technique is the presence only of the
epithelial component.
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1.3.4 Genetically engineered mice
The construction of transgenic mice expressing green fluorescent protein (GFP)
throughout the ureteric bud epithelium allows branching morphogenesis to be
followed by time-lapse confocal microscopy which overcomes the limitation of
examining ureteric bud branching at single time-points (Srinivas et al., 1999).
Introduction of null mutations of the gene of interest in mouse embryonic stem
cells is used for the generation of knockout mice. The role of a particular gene
important for kidney development can be demonstrated. Many key regulators of
kidney development have been identified by gene-knockout technology. The
limitations of this technology is that mice may not have an apparent phenotype
due to redundancy or the gene of interest may be important for early
embryogenesis well before the emergence of the urogenital system or the embryo
dies before organogenesis. Recently the transfection of synthetic small
interfering RNAs (siRNAs) into human cells has been found to effectively inhibit
gene expression and the use of siRNA in mammalian organ culture has been
established (Davies et al., unpublished). Therefore, in the case of genes vital to
early embryogenesis the siRNA-mediated knockdown may establish their role in
kidney development.
1.4 Branching morphogenesis of the developing collecting duct
1.4.1 Branching morphogenesis
Branched tubular epithelial structures are found in most animals and function to
transport gases and liquids in the body. Many organs such as the lung, pancreas,
prostate and kidney are composed of ramifying networks of epithelial tubes.
They develop through branching morphogenesis, which is a commonly used
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developmental mechanism where there is a need of maximization of surface area
relative to the size of the organ.
The branched epithelial tubes arise from initially unbranched epithelial buds of
relatively undifferentiated cells. Subsequent to its initial outgrowth, the bud
undergoes growth, elongation and bifurcation in a highly reproducible way that
leads to the formation of a characteristic three-dimensional, tree-like structure
(Hogan, 1999). The pattern of branching is complex and seldom random. The
earliest branch generations show a highly stereotyped branching pattern, which
suggests that they are under fixed developmental control (Metzger and Krasnow,
1999). For this kind of stereotyped branching to occur, the pattern information
should specify where the branch will bud, the direction it will grow, the size and
shape of the branches and when and where the next generation of branches will
develop (Metzger and Krasnow, 1999).
The development of the branching organs of most vertebrates involves dynamic
and reciprocal interactions between two cell populations, an epithelium and its
mesenchyme. The epithelial bud invades its surrounding mesenchyme as a result
of inducing signals derived from the mesenchyme. The bifurcation of the
epithelial bud is coordinated by positive and negative reciprocal feedback loops
between signaling centers in the mesenchyme and epithelium. Branching of the
epithelial component can proceed by cellular rearrangement alone or it might
require cell proliferation as well.
The pattern of branching morphogenesis can be divided in two types: (i) lateral
branching (also termed monopodial) and (ii) bifid branching (or dipodial). The
former involves lateral branches emerging from a main stem at equally spaced or
random intervals whereas the latter involves the division of the main stem into
two daughter branches of similar size (al-Awqati and Goldberg, 1998; Davies,
2002).
The branching of the ureteric bud is highly structured and shows several types of
repeating patterns of divisions. It requires both lateral and bifid branches, which
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then form three different patterns of branching that unfold one after the other (al-
Awqati and Goldberg, 1998). The first bifurcation of the ureteric bud involves
two symmetric dichotomous branches at an angle of 180° (Saxen, 1987). The
growth and division of ureteric bud branches proceeds in two steps that occur in
rapid succession. The first is a lateral branch emerging from the ureteric bud
stalk, which then divides dichotomously into two terminal branches. This
branching pattern is referred to as a terminal bifid branching system (al-Awqati
and Goldberg, 1998). This is the case because each tip of a branch will induce
and be connected to a nephron. The connection to a nephron removes the tip
from the possibility of further branching (al-Awqati and Goldberg, 1998). The
terminal branches that have stopped their branching programme, retain their
capacity to induce the formation of nephrons that in humans will form the
arcades (Potter, 1972; Saxen, 1987).
1.4.2 Morphogenesis of branched organs
Even though this introduction is mainly about the branching morphogenesis of
the collecting duct system, I will briefly introduce some of the organs that
develop through branching morphogenesis and which are widely used as model
systems for the study of this important developmental mechanism. The following
branching epithelia share anatomical similarities suggesting the idea of
conserved mechanisms. Branching morphogenesis is probably controlled by a
conserved set of molecular mechanisms based on evidence that they share
common signaling pathways, they require members of the same growth factor
families to activate or inhibit branching and their branching pattern is regulated
by the extracellular matrix (Davies, 2002).
The embryonic submandibular salivary glands (figure 1.5) require epithelial-
mesenchymal interactions for proper development. The murine salivary gland
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consists of large and small ducts that terminate in lumen-containing presumptive
acini that express embryonic mucin (Jaskoll and Melnick, 1999). Development
of the submandibular salivary glands is separated into stages: prebud, initial bud,
pseudoglandular, canalicular and terminal bud stages (Jaskoll and Melnick,
1999). The primordium (prebud) arises from the oral epithelium which is of
endodermal origin, interacts with the underlying mesenchyme to form a stalk
with a bulbous lobule (initial bud) (reviewed in Hardman and Spooner, 1992b).
Between embryonic days 12.5 and 13 in mice the primary clefts and lobules are
formed (Miyazaki, 1990). At the end of E13 the epithelial stalk is elongated and
its end consists of three to four primary lobules separated by prominent clefts
(Miyazaki, 1990). During the pseudoglandular stage repeated division at the
distal ends of the buds occurs. A bush-like structure of a network of elongated
epithelial branches with terminal epithelial buds surrounded by loosely packed
mesenchyme is produced (Jaskoll and Melnick, 1999). During canalicular and
terminal bud stages the branches and buds become hollow and form the ductal
system and presumptive acini (Jaskoll and Melnick, 1999).
The mammalian lung (figure 1.5) develops through branching morphogenesis.
The murine lung primordium arises at gestational day 9.5 from the ventral
foregut just anterior of the stomach (for reviews see Hilfer, 1996; Hogan, 1999;
Hogan et al., 1997). Two bud outgrowths of endodermal origin emerge
surrounded by splachnic mesoderm. Lung development progresses in four
morphological stages (Hilfer, 1996). In the earliest embryonic or
pseudoglandular phase the basic branching pattern is established, in the second
or canalicular stage the narrower bronchial passageways are formed by continued
branching. During the third or saccular stage the distal branches expand into
alveolar sacs, at the fourth or alveolar stage more alveolar sacs are formed, and
mature alveoli are formed by outpouching of the alveolar sacs. During the early
(pseudoglandular) stage, the lung is composed of three cell layers: an inner
endodermal epithelium, a splachnic mesodermal mesenchyme and an outer
mesothelium. The two primary buds elongate, and through reciprocal interactions
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of the epithelial-mesenchymal components, undergo branching in a highly
reproducible pattern giving rise to five lobes, four on the right and one on the
left. The mesodermal mesenchyme secretes soluble factors that act on the
branching endoderm. In the early, pseudoglandular stage two branching
mechanisms are used; lateral and dichotomous branching (Ten Have-Opbroek,
1981). The first mechanism establishes the length and overall shape of the main
lobes whereas the dichotomous branching involves the bifurcation of a terminal
bud into two branches, which continue to grow along a different axis.
Formation of the Drosophila tracheal (respiratory) system (figurel.5) involves
branching morphogenesis (Shilo et al., 1997). The tracheal system delivers
oxygen directly to the tissues. It consists of a complex network of hollow
epithelial tubules of ectodermal origin. The tracheal epithelium is a monolayer
without any surrounding support tissue. The tracheal system develops from ten
clusters of ectodermal cells (placodes) on each side of the embryo (Samakovlis et
al., 1996). The clusters invaginate at mid-embryogenesis and form twenty
elongated epithelial sacs of approximately 80 cells. Primary branches emerge
from each sac which grow out in different directions, then secondary branches
emerge from the primary branches and the terminal branches appear as
continuations of the secondary branches at fixed developmental stages
(Samakovlis et al., 1996). The pattern of primary and secondary branching is
stereotyped whereas the pattern of terminal branching varies (Samakovlis et al.,
1996).
Mammary gland development (figure 1.5) proceeds in distinct stages defined by
the hormonal status of the animal (reviewed in Hennighausen and Robinson,
1998). During embryonic development the mammary anlage is established. At
the time of birth it consists of a few rudimentary ducts in the vicinity of the
nipple. Ductal elongation and branching begins after the onset of puberty and the
onset of gonadal hormone secretion. The rudimentary ducts invade the mammary
fat pad through dichotomous branching. Large club-shaped terminal end buds
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emerge. The terminal end buds consist of two histologically distinct cell types:
the body cells which give rise to mammary epithelial cells and the cap cells
which are the precursors of myoepithelial cells (Humphreys et al., 1996).
Branching ceases when the fat pad is laced with the ductal tree. In pregnancy an
expanded lobulo-alveolar compartment develops which obtains functional
differentiation during parturition and lactation.
Another organ that develops through branching morphogenesis and epithelial-
mesenchymal interactions is the pancreas (figure 1.5) (for reviews see Debas,
1997; Scharfmann, 2000; Slack, 1995). It is formed from an evagination of the
foregut of the embryo at E9.5 in mice (Debas, 1997). It develops as two buds on
the dorsal and the ventral side of the duodenum (Slack, 1995). The ventral bud
emerges adjacent to the hepatic diverticulum and the dorsal bud on the opposite
side of the gut tube. After the rotation of the stomach and duodenum the two
buds come into contact and fuse together. As the buds grow they form new
protrusions leading to a branched structure. The epithelial cells of the bud
differentiate into endocrine and exocrine cells. The endocrine cells are grouped
into the islets of Langerhans and the exocrine cells are grouped into acini. Both
the endocrine and exocrine cells of the pancreas develop from the endoderm of
the foregut. Differentiation of the pancreatic cells depends on factors secreted
from the surrounding mesenchyme.
1.4.3 Molecular regulation of ureteric bud branching
morphogenesis
The ramification of an epithelial bud is coordinated by positive and negative
reciprocal feedback loops between the mesenchyme and the epithelial
component. This section focuses on some of the key molecules currently known
to be involved in ureteric bud branching morphogenesis.
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Genes involved in ureteric bud outgrowth and branching
The important role of genes in kidney organogenesis comes from evidence either
through identification of mutations responsible for heritable renal disease, or
through expression studies and from the phenotypes of transgenic knockouts that
show renal defects (for reviews see Davies and Fisher, 2002; Dressier, 1997).
The development of the collecting duct system begins with the outgrowth of the
ureteric bud from the Wolffian duct and subsequent repetitive branching of the
epithelium after invasion of the metanephric mesenchyme. Some of the major
genes involved in these initial stages (i) UB evagination and (ii) branching
morphogenesis are summarized (table 1.1).
Genes requiredfor ureteric bud outgrowth
During early embryogenesis the LIM-homeodomain factor, Lim-1 is expressed in
the Wolffian duct and the ureteric bud (Barnes et al., 1994). Mice lacking Lim-1
show bilateral renal agenesis and absence of the urogenital tract (Shawlot and
Behringer, 1995). Lim-1 and a paired box transcription factor Pax-2 are essential
for the early steps of nephrogenesis and function cooperatively in intermediate
mesoderm (for review Rauchman, 2000). Pax-2 is expressed in both epithelial
and mesenchymal components deriving from the intermediate mesoderm during
the development of pronephros, mesonephros and metanephros (for review see
Dressier and Woolf, 1999). During ureteric bud outgrowth Pax-2 mRNA is
found in the ureteric bud epithelium and the UB branches and induced
mesenchymal condensates (Dressier et al., 1990). Pax-2 homozygous mutant
mice lack kidneys, since the ureteric buds do not form (Torres et al., 1995). Loss
of c-ret expression at the time of the UB outgrowth (see below) accounts for the
lack of ureteric buds in the Pax-2 mutants (Torres et al., 1995). Activation of
GDNF which is responsible for ureteric bud outgrowth (see below) depends on
Pax-2 (Brophy et al., 2001). In humans, a relatively rare disease called Renal-
Coloboma syndrome results from mutations in the PAX2 gene (Eccles et al.,
2003). Patients with PAX2 mutations show urological abnormalities, which
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Table 1.1: Major genes involved during early kidney development
Gene Phenotype Reference
Ureteric bud induction
Lim-1 Bilateral renal agenesis Shawlot and Behringer, 1995
Pax-2 Agenesis Torres etal., 1995
WT-1 Agenesis Kreidberg et al., 1993
Eya-1 Agenesis (-/-), renal hypoplasia & unilateral Xu etal., 1999
agenesis (+/-)
Sall-1 Renal agenesis or severe dysgenesis Nishinakamura et al., 2001
Foxcl Hydronephrosis & hydroureter Kume et al., 2000
Id Bilateral renal agenesis or renal hypoplasia Maas et al., 1994
GDNF Bilateral renal agenesis Moore et al., 1996
c-ret Agenesis or severe hypodysplasia Schuchardt etal., 1996
UB branching morphogenesis
Emx-2 Lack of urogenital system Miyamoto et al., 1997
Hoxa11/d11 Rudimentary or absent kidneys Patterson et al., 2001
Bf-2 Reduced size of collecting duct system, Hatini et al., 1996
reduction in UB branching, reduced
nephron no.
RARa/p2 Small kidneys, impaired UB branching, Mendelsohn et al., 1994;
reduced nephron no. Mendelsohn et al., 1999
UB: ureteric bud
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involve hypoplastic kidneys with decreased renal function and occasionally
unilateral renal agenesis (Eccles et al., 2003).
The Wilms tumour-associated gene, WT-1, has been identified as an important
gene involved in early kidney development (Kreidberg et al., 1993). During the
initial stages of metanephric development it is expressed in the uninduced
metanephric mesenchyme and homozygous mutant mice show mid gestation
lethality and lack kidneys (Kreidberg et al., 1993). In El 1.5 mutant embryos the
ureteric buds are absent, the mesenchyme present is apoptotic and does not
express Pax-2 (Kreidberg et al., 1993).
Mice lacking the Eya-1 gene, a homologue of the Drosophila gene eyes absent
(eya), lack kidneys (Xu et al., 1999). Eya-1 is expressed initially in the
uninduced mesenchyme (El0.5) and thereafter in the induced mesenchyme (Xu
et al., 1999). In homozygous mutant mice the ureteric bud fails to invade the
mesenchyme which becomes apoptotic (Xu et al., 1999). Another gene expressed
in the metanephric mesenchyme but not the ureteric bud epithelium at the time of
the epithelial evagination is Sall-1 (Sal like-1), a mammalian homologue of the
Drosophila region specific homeotic gene spalt (sal) (Nishinakamura et al.,
2001). It is essential for early metanephric development as loss of Sall-1 results
in renal agenesis or dysgenesis due to lack of ureteric bud invasion of the
metanephric mesenchyme and subsequent apoptosis of the uninduced
mesenchyme (Nishinakamura et al., 2001). In humans, mutation of the SALL1
gene results in renal dysplasia and lower urinary tract malformations in Townes-
Brockes syndrome (Woolf et al., 2003). The metanephric expression of the
transcription factors Foxcl/Mfl (Mesoderm/mesenchyme forkhead-1) and
Foxc2/Mfhl (Mesenchyme forkhead-1) is overlapping and concentrated at El0.5
in the uninduced mesenchyme but not in the epithelium (Kume et al., 2000).
Their loss is responsible for the formation of duplex kidneys and double ureters
with unilateral fluid filled dilation of the kidney and ureter in mice (Kume et al.,
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2000). This phenotype is a result ofmore anterior expression ofGDNF and Eya-
1 transcripts leading to formation of ectopic ureteric buds (Kume et al., 2000).
Formins are nuclear proteins expressed in both the metanephric mesenchyme and
ureteric bud at the time of the kidney induction (El 1.5) (Maas et al., 1994). The
loss of formin in mice homozygous for the limb deformity (Id) mutation, results
in renal abnormalities ranging from agenesis to renal hypoplasia due to deficient
ureteric bud outgrowth (Maas et al., 1994).
Genes requiredfor ureteric bud branching
Hox genes are a family of clustered genes that encode homeodomain-containing
transcription factors. Mutant mice of either Hoxall or Hoxdll have normal
kidneys suggesting functional redundancy whereas double mutants have
rudimentary or in extreme cases absent kidneys (Patterson et al., 2001). Their
expression in the early developing kidney is similar and is restricted to the caudal
end of the intermediate mesoderm (Patterson et al., 2001). At the time of ureteric
bud evagination their expression is found in the metanephric mesenchyme
surrounding the emerging ureteric bud and the expression continues in the
induced mesenchyme surrounding the branching ureteric tips (Patterson et al.,
2001). In the double mutant mice, the ureteric bud emerges from the Wolffian
duct as in the wild type embryos of the same age. However in the most severe
cases the ureteric bud does not grow or branch further; in the less severe cases its
branching is impaired in the mid-ventral region of the kidney (Patterson et al.,
2001). The mutant mesenchyme shows downregulation of mesenchymal markers
such as WT-1 and Pax-2 suggesting a defective response to ureteric bud
induction (Patterson et al., 2001). There is also a reduced expression of GDNF
from the ventral region at the area of the branching defect (Patterson et al.,
2001).
Emx-2 is a homeobox transcription factor expressed in the ureteric epithelium at
the time of the ureteric bud induction (El 1.5) but not in the mesenchyme or the
pretubular aggregates (Miyamoto et al., 1997; Pellegrini et al., 1997). Mice
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lacking emx-2 show lack of urogenital system (Miyamoto et al., 1997). The
ureteric bud at El 1.5 invades the mesenchyme bud there is no dilation of the bud
tip and no further branching (Miyamoto et al., 1997). Loss of emx-2 affects the
epithelial compartment since in the mutant embryos (at El 1.5) the mesenchymal
markers WT-1 and Pax-2 are expressed normally whereas there is a reduction of
c-ret and GDNF expression essential for ureteric bud branching (see below)
(Miyamoto et al., 1997).
The Wnt gene family comprises one superfamily of developmentally important
signaling molecules which are involved in metanephric development (for review
see Cadigan and Nusse, 1997; Carroll and McMahon, 2000; Vainio et al., 1999).
In early metanephric development Wnt-2b is expressed as early as El 1.5 in the
perinephric mesenchymal cells as well as in the mesenchymal cells in the region
close to the stalk of the ureteric bud and supports ureteric bud growth and
branching in culture (Lin et al., 2001a). Wnt-6, Wnt-11 and Wnt-7b are expressed
in the ureteric epithelium (Lin et al., 2001a; Kispert et al., 1996). Wnt-11 is
expressed specifically at the tip of the branching epithelium, expression which
correlates with the sites of epithelio-mesenchymal interactions and its expression
is regulated by GDNF and sulphated proteoglycans (see below) whereas Wnt-7b
expression is excluded from the tip and is suggested to play a role in duct
maintenance and growth (Carroll and McMahon, 2000; Kispert et al., 1996).
Stromal genes requiredfor ureteric bud branching
The metanephric mesenchyme will give rise to both the epithelial cells of the
nephrons and the stromal cells of the mature kidney. Foxdl/Bf2 (Brain factor-2)
is expressed specifically in the stromal mesenchymal cells of the kidney (Hatini
et al., 1996). At El2.5 it is restricted to a population of cells that surround the
condensations of the metanephric mesenchyme, and at later stages its expression
is detected in the cortical stroma that surrounds differentiating nephrons (Hatini
et al., 1996). Homozygous mutant mice die after the first 24 hours after birth
from renal abnormalities (Hatini et al., 1996). In the mutant mice, the ureteric
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bud shows an abnormal branching pattern probably due to ectopic c-ret
expression as well as a 8- to 16- fold reduction in the number of branches, with
abnormally large mesenchymal condensates (Hatini et al., 1996).
The retinoic acid receptor (RAR) p2 is expressed in the stromal cells surrounding
the ureteric bud and the induced mesenchyme (El2), overlapping with Bf-2
expression (Mendelsohn et al., 1999). RARa is also expressed in the embryonic
kidney in the ureteric bud, metanephric mesenchyme and stromal cells where is
co-expressed with RARP2 (Mendelsohn et al., 1999). Generation of RARa/p2
double homozygous mice results in renal defects which demonstrate the essential
function of retinoids during metanephric development (Mendelsohn et al., 1994).
The double mutants exhibit bilateral renal hypodysplasia (often ectopic) which is
also associated with dilation of the renal pelvis (hydronephrosis) (Mendelsohn et
al., 1994). The ureteric bud of the double mutant embryonic kidneys display
impaired branching morphogenesis with a fourfold reduction in the number of
tips compared to wild type embryos of the same age accompanied with a
reduction in c-ret expression (Mendelsohn et al., 1999). Restoring c-ret
expression in the ureteric bud epithelium has been shown to rescue the ureteric
bud branching in RARa/p2 double homozygous mice (Batourina et al., 2001).
The role of secreted peptide growth factors
Research evidence has shown that several secreted peptide growth factors,
expressed in the ureteric bud or the metanephric mesenchyme, exert regulatory
effects on ureteric bud branching morphogenesis in vivo and in vitro. Some of
them include members of the Transforming growth factor (TGF-) p superfamily,
the Fibroblast growth factor (FGF) family, and HGF/SF (figure 1.6; table 1.2).
GDNF and related neurotrophic factors
The glial cell line-derived neurotrophic factor (GDNF) family consists of five
members (GDNF, neurturin, persephin, artemin and enovin) which are distant
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(From Davies and Fisher, 2002)
Figure 1.6: Key regulatory signals during ureteric bud
branching morphogenesis
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Integrins a3 & a6
MMP-2 & -9
Abnormal UB branching pattern with failure to Ritvos etal., 1995
produce many secondary branches (OC)
Inhibits branching (3DC)
Reduction in branching (T)
Promotes elongation of UB (OC)
Low doses stimulate branching (3DC)
High doses inhibit branching (3DC)
Promotes elongation of UB branches (IUBC)
Promotes growth of UB (IUBC)
Promotes growth of UB (IUBC)
Promotes elongation of UB branches (IUBC)
Promotes UB outgrowth from WD (OC)
Promotes branching (OC)
Promotes branching, rescues elongation of UB
branches (OC)
Slight increase in UB branching, rescues UB
branching (OC)
Rescues UB branching (OC)
Promotes branching (IUBC), promotes growth
of UB (OC)
Inhibits UB growth, abnormal branching with
long UB branches (OC), inhibits branching
(3DC)
Required for UB branching (OC, T)
Impaired UB branching (T)
Required for UB branching (OC)
Required for UB branching (OC)
Signal transduction pathways
Erk MAP kinase Required for UB branching (OC)
PI3 kinase Required for UB branching (OC)
Protein kinase A Inhibition of branching (3DC)
Piscione etal., 1997
Miyazaki et at., 2000
Piscione et al., 1997
Qiao et al., 2001
Qiao et al., 2001
Qiao et al., 2001
Qiao et al., 2001
Sainio et al., 1997,
Towers et al., 1998,
Vega et al., 1996
Woolfefa/., 1995,
Davies et al., 1995
Davies et al., 1999
Milbrandt et al., 1998
Sakurai et al., 2001
Clark et al., 2001,
Ritvos et al., 1995,
Santos and Nigam, 1993
Davies et al., 1995,
Bullock et al., 1998
Muller et al., 1997
Zentef al., 2001
Barasch et al., 1999,
Lelongt et al., 1997
Fisher et al., 2001
Tang et al., 2002
Gupta et al., 1999
3DC: data from three-dimensional tubulogenesis model culture experiments, IUBC: data from isolated ureteric
bud culture model experiments, OC: data from organ culture experiments, T: data from transgenic mice, UB:
ureteric bud, WD: Wolffian duct
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members of the TGF-P superfamily (reviewed in Masure et al., 1999; Saarma,
2000). The neurotrophic factor GDNF is the first member of the GDNF family
and was identified by its ability to promote the survival of midbrain
dopaminergic neurons in culture. GDNF does not signal through receptor
serine/threonine kinases but activates the transmembrane receptor tyrosine kinase
(RTK) Ret (Worby et al., 1996). GDNF induced activation of the Ret protein
kinase requires the specific binding of the ligand to a glycosyl-phosphatidyl
inositol- (GPI-) linked cell surface protein called GDNF family receptor al
(GFRal) (Jing et al., 1996). The amino acid homology between the members of
the GDNF family is between 40 and 50%. They all signal through the activation
of the receptor tyrosine/kinase Ret and one of four GPI-anchored proteins
GFRal-4 (reviewed in (Rosenthal, 1999; Saarma, 2000). Neurturin binds to
GFRa2, artemin binds to GFRa3 and persephin activates Ret by binding to
GFRa4 (Saarma, 2000). GDNF, NTN and artemin cross-talk weakly with other
GFRa receptors (reviewed in Rosenthal, 1999; Saarma, 2000). GDNF can also
activate Ret by binding to GFRa2 (Sanicola et al., 1997).
In the murine developing kidney GDNF, Ret and GFRal level of mRNA
expression is high from E12 through to E18 (Golden et al., 1999). The receptors
are primarily expressed in the branching tubular epithelial components whereas
GDNF is expressed in the areas of the surrounding mesenchyme (Golden et al.,
1999; Moore et al., 1996). At earlier stages (E9-E10.5), Ret is expressed in the
nephric duct of the pronephros and mesonephros (Pachnis et al., 1993). At more
advanced stages (E13.5- E17.5) Ret expression is confined to the tips of the
branching ureteric bud and not to the mesenchymal-derived epithelial
components (Pachnis et al., 1993). GFRal mRNA is detected in the terminal
buds and at low levels in the mesenchyme closely associated with the terminal
buds (Towers et al., 1998). GFRal protein is found localized to the ureteric bud
as well as the condensed mesenchymal cells of the comma- and S- shaped bodies
(Ehrenfels et al., 1999).
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Mice lacking GDNF show complete bilateral renal and ureteral agenesis (Moore
et al., 1996). Heterozygous embryos show an increased incidence of unilateral
renal agenesis or hypoplasia with approximately 30% fewer nephrons (Cullen-
McEwen et al., 2001; Moore et al., 1996). Newborn mice, homozygous for a
mutation in c-ret, display renal agenesis or severe hypodysplasia (Schuchardt et
al., 1996). In the mutant kidneys, at the embryonic days 11 and 12.5, the ureteric
buds either never contact the mesenchyme or their entering is delayed. When the
mutant ureteric buds have entered the mesenchyme the branching pattern appears
abnormal (Schuchardt et al., 1996). Mice lacking the GFRal co-receptor
demonstrate renal agenesis or unilateral or bilateral dysgenesis, phenotypes
similar to those of GDNF and Ret-deficient mice whereas the heterozygotes
show no kidney defects (Cacalano et al., 1998; Enomoto et al., 1998). The
metanephric mutant kidneys (El 1.5), show lack of formation of the ureteric bud
or inability of the UB to penetrate the metanephric mesenchyme. This leads to
failure of the latter to form condensates hence the small nephron numbers
observed after the histological analysis of the dysplastic kidneys (Enomoto et al.,
1998).
At early developmental stages (El0.5), local application of a GDNF source
promotes the initiation of ureteric bud in culture (Brophy et al., 2001; Sainio et
al., 1997b). Since GDNF is expressed at the mesenchyme around the tips of the
ureteric bud it is has been reported that it binds directly to the tips (Sainio et al.,
1997b; Towers et al., 1998). In culture, addition of exogenous GDNF results in
an increase in number of branching ureteric bud tips whereas blocking GDNF
function results in a reduction in branching morphogenesis (Towers et al., 1998;
Vega et al., 1996). In kidneys cultured in chlorate, addition of exogenous GDNF
results in the rescue of ureteric bud branching (Sainio et al., 1997b). Local
application ofGDNF attracts the ureteric bud branches towards the growth factor
source suggesting a chemoattractant effect (Sainio et al., 1997b; Tang et al.,
1998). Recently the Erkl/2 mitogen-activated protein kinase (MAP kinase) and
the phosphoinositide 3-OH kinase (PI-3 kinase) have been identified to act
40
downstream of GDNF signaling regulating ureteric bud branching (Fisher et al.,
2001; Tang et al., 2002).
Neurturin (NTN) is expressed at the ureteric bud as early as El0.5 in mice
(Davies et al., 1999). At later embryonic stages (E16, El8) its expression is
increased but is detected to a moderate level in relation to the expression of Ret
and GDNF (Golden et al., 1999). Both neurturin and its receptor GFRa2 are
primarily expressed in the branching tubular epithelial components of the
developing metanephros suggesting an autocrine role (Davies et al., 1999;
Golden et al., 1999). In organ culture, addition of NTN results only in a slight
increase of ureteric bud branching probably due to the presence of endogenous
GDNF (Davies et al., 1999). Addition of neurturin in organ cultures in the
presence of function blocking anti-GDNF results in an increase of ureteric bud
branching (Davies et al., 1999).
Persephin (PSP) mRNA is expressed at low levels in the developing rat
metanephric kidney (Er18) (Milbrandt et al., 1998). In murine kidney organ
cultures when branching morphogenesis is blocked (treatment with sodium
chlorate that deprives them of sulphated proteoglycans (Davies et al., 1995)(see
below) the addition of PSP rescues the branching (Milbrandt et al., 1998).
Transforming Growth Factors-(5 and Activin
Transforming growth factors-P (TGF-P) are expressed throughout
embryogenesis and their receptors are ubiquitously expressed (reviewed in
Massague, 1990). Three isoforms of TGF-P have been identified in mammals:
TGF-P 1, 2, and 3. The biological activities of the TGF-P are diverse: they
control cell proliferation either in a stimulatory or inhibitory fashion, they control
cell adhesion by enhancing synthesis and deposition of extracellular matrix
components and they also promote cell differentiation (reviewed in Massague,
1990; Moses et al., 1990).
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Expression of TGF-p is high in sites undergoing intense development and
morphogenesis including the epithelial/mesenchyme interface (Lehnert and
Akhurst, 1988). TGF-P 1 mRNA is expressed by the mesenchymal cells that will
develop into stroma, at E15.5 in mice (Lehnert and Akhurst, 1988). At earlier
stages (E12.5) only TGF-p2 is present in the embryonic kidney at a very
restricted pattern in the basement membrane of the cuboidal epithelium (Pelton et
al., 1991).
In culture, TGF-P exerts an inhibitory effect on kidney growth and branching
morphogenesis. In mouse organ culture, addition of TGF-p results in an
abnormal branching pattern where the ureteric bud appears to grow rapidly in
length and does not branch until it reaches the periphery of the metanephric
mesenchyme (Ritvos et al., 1995). In rat metanephric organ cultures, addition of
TGF-p 1 inhibits the overall organ growth accompanied with reduced nephron
number (Clark et al., 2001; Rogers et al., 1993). A similar effect is seen with the
addition of TGF-P2 in rat organ cultures, which significantly impairs ureteric
growth and results in smaller kidneys (Martinez et al., 2001). In the MDCK
tubulogenesis model, addition of TGF-P results in inhibition of tubulogenesis
and formation of branching processes (Santos and Nigam, 1993). Even though
TGF-P seems important for ureteric bud branching in culture, TGF-P 1
homozygous null mutant mice do not display kidney defects (Kulkami and
Karlsson, 1993).
Inhibins and activins are members of the TGF-P family. Activins are
hetero/homodimers of two closely related subunits (PaPa, PbPb and PaPb)
(reviewed in Massague, 1990). In the developing kidney the Pb subunit is
detected in the kidney capsule, the Pa subunit transcripts are detected in the
smooth muscle cells surrounding the ureter (El7) and none is detected on the
ureteric epithelium (Ritvos et al., 1995). However, the addition of activin in El 1
kidney organ culture disrupts normal branching morphogenesis. Branching is
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delayed, characterized by abnormally short intercalating distances between
branches and by failure to produce as many secondary branches as the control
metanephroi (Ritvos et al., 1995).
Bone morphogeneticproteins
Members of the bone morphogenetic protein (BMP) family, a subgroup of the
TGF-P superfamily, have been shown to be important signaling molecules
throughout mouse development, and many BMPs display dynamic expression
patterns during murine kidney organogenesis (for review see Godin et al., 1999).
Bone morphogenetic protein 2 (BMP-2) is expressed in the induced
mesenchymal pretubular aggregates and in culture is found to be inhibitory,
resulting in short ureteric buds (Godin et al., 1999; Piscione et al., 1997). In the
mIMCD-3 cell model of tubulogenesis, the BMP-2 inhibitory effect is more
potent than any other member of the TGF-P superfamily (Piscione et al., 1997).
In this tubulogenic model system BMP-2 regulates branching morphogenesis via
Smadl/4 signaling pathway and by activation of protein kinase A (PKA) (Gupta
et al., 2000; Gupta et al., 1999).
Heterozygous Bmp4 null mutant mice show renal defects that mimic human
congenital anomalies of the kidney and urinary tract (CAKUT), and the kidney
hypo/dysplasia results from reduced branching of the ureter (Miyazaki et al.,
2000). Bone morphogenetic protein 4 (BMP-4) is expressed in the mesenchymal
cells that surround the Wolffian duct (at El0.5), then is expressed at the stromal
mesenchymal cells surrounding the main trunk and the stalk of the branching
ureteric bud (at E12.5) but not around the tip (Miyazaki et al., 2000). Results
from culture experiments showed that BMP-4 does not increase the number of
branches, however it is important for bud growth and elongation (Miyazaki et al.,
2000). BMP-4 specifically inhibits GDNF signaling to or within the ureteric
epithelium without directly modulating the expression pattern of GDNF itself
(Miyazaki et al., 2000). In the mutant mice the ureteric bud evaginates cranially
from the WD (Miyazaki et al., 2000) suggesting that BMP-4 probably regulates
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the initial ureteral budding by antagonizing GDNF signaling on the WD (Brophy
et al., 2001).
Embryos lacking BMP-7 show abnormalities in renal and ocular systems
(Dudley et al., 1995; Luo et al., 1995). Most of the mutant embryos display
severe bilateral renal dysplasia and die within the first 24 hours postpartum from
renal failure (Dudley et al., 1995). BMP-7 is expressed at the Wolffian duct
before ureteric bud outgrowth and at the epithelium during its evagination
(Godin et al., 1998). At El 1.5 BMP-7 is expressed in the ureteric bud and
surrounding mesenchyme, at El3.5 it is expressed at the epithelium and
condensed mesenchyme associated with the ureteric bud tips (Godin et al.,
1998). At later stages of development, BMP-7 is detected at the mesenchymal
stem cells, condensing aggregates, and the epithelia of the comma and S-shaped
pretubular structures, with weaker expression found in the ureteric ducts (Dudley
et al., 1995). In three dimensional culture models, low doses of BPM-7 were
found to stimulate the branching of the ureteric bud whereas higher doses were
inhibitory (Piscione et al., 1997).
Fibroblastgrowth factors
Members of the fibroblast growth factor (FGF) family are known regulators of
epithelial growth and branching morphogenesis in other organs such as the
mammalian embryonic lung and the Drosophila trachea (Bellusci et al., 1997;
Metzger and Krasnow, 1999; Morita and Nogawa, 1999; Weaver et al., 2000).
FGF members and their receptors are expressed at the embryonic kidney. Nine
FGFs (FGF-1 through FGF-5 and FGF-7 through FGF-10) are expressed early
(from at least Er14) in rat metanephric development and continue to be expressed
throughout metanephrogenesis (Cancilla et al., 1999). However knockout mice
for FGF-2, 3 and 5 do not have any obvious kidney defects (Cancilla et al.,
1999). Only the FGF-7 mutant mice show kidney defects, with smaller ureteric
buds, mature renal collecting system and 30% fewer nephrons than the wild type
kidneys (Qiao et al., 1999b). In rat organ cultures blocking FGF-7 results in
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reduction in branching morphogenesis of the ureteric bud (Qiao et al., 2001).
FGF-7 is expressed at the stroma surrounding the growing ureteric bud and is
suggested to influence ureteric bud growth (Qiao et al., 1999b). However it is
first detected in mice at E14.5, suggesting that the ureteric bud growth between
embryonic days 11.5 to 13.5 is regulated by other than FGF-7 factors (Qiao et
al., 1999b). The effect of FGFs on ureteric bud branching morphogenesis comes
from evidence on the isolated ureteric bud culture system (Qiao et al., 2001;
Qiao et al., 1999a; Sakurai et al., 1997; Sakurai et al., 2001). FGF-1, -2, -7 and -
10 facilitate UB branching although their ability to induce branching
morphogenesis is different (Qiao et al., 2001). FGF-1 and FGF-10 produce
elongated branching tubular structures with clear distinction between stalk and
ampullae regions whereas FGF-2 and FGF-7 result in the formation of less
ordered structures which are more globular with less distinct areas between
ampullae and stalks (Qiao et al., 2001).
Pleiotrophin andMidkine
Recently, pleiotrophin, an 18 kDa heparin-binding protein was identified as a
paracrine mesenchymal factor involved in ureteric bud branching morphogenesis
(Sakurai et al., 2001). Addition of pleiotrophin and GDNF was found to be
capable of inducing branching morphogenesis in isolated ureteric buds cultured
within an extracellular matrix gel [1:1 mixture of growth factor reduced Matrigel
and Type I collagen] (Sakurai et al., 2001). In rats, pleiotrophin mRNA is
expressed at the metanephric mesenchyme during developmental stages Er15 and
Er17 (Vanderwinden et al., 1992). In the mouse, the protein is found to be
present in the mesenchyme and the ureteric bud at early development (El 2.5-
E13.5), whereas at later stages (E14.5- E16.5) it is absent from the mesenchyme
and is localized on the surfaces of the epithelial cells (Mitsiadis et al., 1995).
Sakurai and others have also found the protein present at the basement
membrane of the developing ureteric bud at an even earlier stage (El 3) (Sakurai
et al., 2001). In organ culture, exogenous pleiotrophin stimulates ureteric bud
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growth and results in an enlargement of the whole rudiment (Sakurai et al.,
2001).
Midkine (MK) is a heparin-binding molecule sharing a 50% sequence identity
with pleiotrophin, that can be induced in some cell types by treatment with
retinoic acid (Mitsiadis et al., 1995). In embryonic murine metanephros MK, like
pleiotrophin, is found in both metanephric mesenchyme and ureteric epithelium
at developmental stages E12.5-E13.5 (Mitsiadis et al., 1995). Unlike
pleiotrophin, MK is present at both basement membranes of collecting ducts and
condensing mesenchyme (E14.5) (Mitsiadis et al., 1995) suggesting that MK
may exert effects on either mesenchymal or epithelial cells. However, knockout
mice lacking the MK gene develop normally, showing no kidney defects
(Nakamura etal., 1998).
Hepatocyte growth factor
The hepatocyte growth factor/ scatter factor (HGF/SF) was identified as a
mesenchymal cell-derived cytokine with diverse effects on different target cells
during normal development, regeneration and carcinogenesis (reviewed in
Birchmeier and Gherardi, 1998; Montesano et al., 1991a; Rosen et al., 1994).
The biological activity of HGF expands in a wide range as it dissociates
epithelial sheets into individual cells, it stimulates cell motility and invasion, is
mitogenic and a potent morphogen of epithelial cells (reviewed in Balkovetz,
1998; Birchmeier and Gherardi, 1998; Rosen et al., 1994).
HGF is a heparin-binding glycoprotein, which belongs to the plasminogen-
related growth factor family and signals through receptor tyrosine kinase which
is encoded by the c-met proto-oncogene (Birchmeier and Gherardi, 1998; Rosen
et al., 1994). In the embryonic kidney, both HGF and c-met are expressed from
El 1.5 onwards corresponding to the onset of tubulogenesis and branching
morphogenesis (Santos et al., 1994). At that time HGF mRNA is detected in the
metanephric mesenchyme, and met transcripts are detected both in the
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mesenchyme and the ureteric bud (Woolf et al., 1995). By E14 the highest
expression of the receptor is detected in the branching tips of the ureteric bud
(Woolf et al., 1995). Blocking of HGF in culture, inhibits growth of the kidney
rudiments, reduces the ureteric bud branching, limits nephron formation and is
associated with an increase in apoptosis in mesenchymal cells (Santos et al.,
1994; Woolf et al., 1995). Furthermore, the tips of the ureteric bud branches
appear dilated or cystic (Woolf et al., 1995). HGF also promotes ureteric branch
elongation in sulphated glycosaminoglycans-deprived kidneys in culture (Davies
et al., 1995). Mice lacking HGF do not show any kidney defects (Uehara et al.,
1995).
HGF is secreted as an inactive zymogen and must be cleaved by a serine protease
to initiate Met signaling (for review Rosen et al., 1994). A serine protease
specific for HGF, HGF activator (HGFA) is expressed and activated by the
ureteric bud (van Adelsberg et al., 2001). HGFA is found localized around the
ampullae of the ureteric buds (van Adelsberg et al., 2001). Blocking the
activation of HGF with protease inhibitors in vitro, results in smaller,
dysmorphic kidneys with reduced branching morphogenesis as well as reduced
nephrogenesis and glomerulogenesis (van Adelsberg et al., 2001).
The three biological responses induced by HGF (scattering, growth and
branching morphogenesis/tubulogenesis) are mediated by a variety of signaling
pathways (reviewed in Balkovetz, 1998). Research evidence from the MDCK
and mIMCD-3 two-dimensional and three-dimensional (tubulogenesis) models
has shown that HGF signaling is dependent on protein kinase C, protein kinase A
(Santos et al., 1993), PI 3-kinase (Khwaja et al., 1998) as well as the Ras-
Rac/Rho pathway, p42/44 MAP kinase (Karihaloo et al., 2001b; Ridley et al.,
1995) and the signal transducers and activator of transcription (STAT) pathway
(Boccaccio et al., 1998).
The role of the extracellular matrix
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Mammalian organogenesis and especially branching morphogenesis is
characterized by extensive tissue growth and remodeling. The ureteric bud cells
are surrounded by extracellular matrix proteins which function as to provide
mechanical support as well as to mediate biological processes such as cell
adhesion and motility. The dynamic remodeling of the extracellular matrix
during ureteric bud growth and ramification in coordination with gene expression
and the auto/paracrine regulatory molecules result in the formation of the
collecting duct tree (reviewed in Wallner et al., 1998).
Extracellular matrixproteins and Integrins
Proteoglycans (PG) are macromolecules composed of glycosaminoglycan (GAG)
chains covalently bound to a protein core (reviewed in Kjellen and Lindahl,
1991). Proteoglycans may occur intracellularly, at the cell surface or in the
extracellular matrix and their role ranges from mechanical support to functions in
adhesion, motility, proliferation, differentiation and morphogenesis (Kjellen and
Lindahl, 1991). Hyaluronan (HA), the largest of the glycosaminoglycans, and its
receptor CD44 are found localized near the basal cell surface of the developing
ureteric bud and at the basolateral surfaces ofUB-derived structures respectively
(Pohl et al., 2000). In a three-dimensional tubulogenesis model blocking the HA-
CD44 axis prevents the branching morphogenesis (Pohl et al., 2000). In the same
tubulogenesis model (isolated UB-cells) the receptor is localized at the tips of the
branching tubules indicating a function in tip elongation (Pohl et al., 2000).
Heparan sulphate PGs are expressed at the surface ofmost animal cells, and have
been implicated in the presentation of a number of signaling molecules to their
receptors during signal transduction (reviewed in Bernfield et al., 1999). They
are important during early kidney development (reviewed in Davies et al., 2001).
Syndecan-1 is strongly expressed at the tips of the ureteric bud and at the
condensing mesenchyme around them (Davies et al., 1995; Vainio et al., 1989).
Heparan and chondroitin sulphates are expressed in the basement membranes of
the ureteric bud epithelium and the mesenchymal matrix (Davies et al., 1995).
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The necessity for GAGs in ureteric bud branching morphogenesis in vivo has
been demonstrated by a heparan-sulphate-2-O-sulphotransferase-knockout
mouse which exhibits bilateral renal agenesis (Bullock et al., 1998). Mutant mice
at El 1.5 and El2.5 contain unbranched ureteric buds with no signs of
mesenchymal condensation (Bullock et al., 1998). In organ cultures, treatment of
embryonic kidneys with enzymes that destroy existing glycosaminoglycans
impaired ureteric bud branching morphogenesis (Davies et al., 1995). Treatment
of kidneys with sodium chlorate, a specific sulphation inhibitor, which competes
with sulphate for sulphotransferase enzymes and blocks the formation of new
glycosaminoglycan chains results in failure of ureteric bud development (Davies
et al., 1995). Sulphated proteoglycans are important for the maintenance of Wnt-
11 expression in the tips of the ureteric bud (Kispert et al., 1996). Ret expression
is also lost from the tips of the epithelium in chlorate treated kidneys (Kispert et
al., 1996). GDNF requires sulphated GAGs for GDNF-receptor binding (Barnett
et ah, 2002).
Glypicans are a family of GPI-linked cell surface heparan sulfate proteoglycans
which control cellular responses to growth factors and cell proliferation and
apoptosis (Cano-Gauci et al., 1999). Mice lacking glypican-3 (GPC3) exhibit
several of the clinical features observed in patients with the Simpson-Golabi-
Behmel syndrome (SGBS), including developmental overgrowth, lung
abnormalities and display cystic and dysplastic kidneys (Cano-Gauci et al.,
1999). The ureteric bud of the E12 mutant kidneys shows a larger number of
ureteric bud branches (Cano-Gauci et al., 1999).
Basement membrane components and their receptors have been implicated in the
regulation of epithelial morphogenesis of developing branching organs such as
the salivary gland (Hardman and Spooner, 1992a; Kadoya and Yamashina,
1989). Laminins are a large family of extracellular glycoproteins found in
basement membranes. Laminins interact with integrin type of receptors on the
cell surface, but binding to other proteins such as dystroglycan as a high affinity
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receptor for laminin-1, and nidogen as a high-affinity laminin-binding protein
important for basement-membrane assembly has also been demonstrated
(Durbeej and Ekblom, 1997; Ekblom et al., 1998). Nidogen is produced by the
metanephric mesenchyme of the developing kidney (Ekblom et al., 1994).
Antibodies blocking laminin-nidogen interaction in vitro result in altered
morphogenesis of E12 kidneys with fewer ureteric bud branches and less newly
formed epithelium around the tips (Ekblom et al., 1994). Laminin-5 is also
expressed on the basement membrane of both the Wolffian duct and ureteric bud
(Ell) (Airenne et al., 2000). Addition of a function blocking antibody against
Laminin-5 results in smaller kidney rudiments with less ureteric bud branching
(Zent et al., 2001).
Many of the interactions between cells and the extracellular matrix are mediated
by the integrin family of cell surface receptors (reviewed in Juliano and Haskill,
1993; Katz and Yamada, 1997; Tarone et al., 2000). Integrins are heterodimeric
transmembrane glycoproteins, composed of a single a and P peptide subunit that
can associate in various combinations (Hynes, 1992). A single P subunit is able
to form heterodimers with several a subunits, while the a subunit largely
determines the substrate specificity with ECM proteins (Tarone et al., 2000).
Integrins play a crucial role in tissue and organ morphogenesis as they bind to
cytoskeletal proteins of the actin contractile system thus directly mediating cell
attachment, spreading and migration and also mediate and co-participate in the
activation and regulation of signal transduction pathways (Katz and Yamada,
1997; Tarone et al., 2000).
Mutations in the a3 and a8 integrin genes have resulted in renal defects
suggesting a role in collecting duct development (Kreidberg et al., 1996; Muller
et al., 1997). Ligands for the a3pi integrin include laminin (Laminin-1 and -5),
certain type of collagen, fibronectin and entactin (nidogen) (Kreidberg et al.,
1996). Ligands for the a8pi include fibronectin, vitronectin and tenascin-C
(Muller et al., 1997).
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During kidney development (at E14), a3pi integrin is expressed by podocytes in
the glomeruli and on collecting ducts suggesting that it is a receptor for the
basement membrane of these cells (Kreidberg et al., 1996). The a3 mutant mice
die within the first 24 hours after birth with severe renal abnormalities, which
include small sized kidneys and presence of stromal component between the
collecting ducts in the renal medulla (Kreidberg et al., 1996). In the developing
kidney, a8pi is expressed at the mesenchymal component as early as Ell
corresponding to the ureteric bud outgrowth from the WD (Muller et al., 1997).
Upon branching of the ureteric bud, expression of the a8 integrin subunit is
present at the mesenchymal condensates surrounding the tips of the branching
epithelium and at the pretubular aggregates but not on comma- or S- shaped
bodies (Muller et al., 1997). The a8 homozygous mutant mice show a variety of
renal defects ranging from kidney agenesis (where the ureteric bud has not
invaded the mesenchyme) to dysgenesis (where the ureteric bud shows defective
branching morphogenesis and the epithelialization of the metanephric
mesenchyme is impaired) (Muller et al., 1997).
Evidence from in vitro models, have suggested roles for the a3, a6, pi and p4
subunits on ureteric bud branching morphogenesis (Zent et al., 2001). In rat
organ cultures, blocking the function of the a3 subunit with function blocking
antibody disrupts both the branching and elongation of the ureteric bud (Zent et
al., 2001). In the same culture system, blocking the pi subunit also results in
impaired branching morphogenesis (Zent et al., 2001). The integrin a6 subunit is
known to associate with either the pi or P4 subunits to form the laminin
integrins a6pi and a6p4 (Durbeej and Ekblom, 1997). The a6 integrin subunit
is present in the ureteric bud predominantly as integrin a6p4 and blocking of
either subunits with function blocking antibodies in organ cultures results in
reduction in branching morphogenesis of the ureteric epithelium (Zent et al.,
2001). The addition of a combination of function blocking antibodies to subunits
a3 and a.6 results in a dramatic effect on UB branching in culture, whereas in the
double mutant embryos a3~/'/a6" the ureteric buds show no defects (De
Archangelis et al., 1999; Zent et al., 2001).
Extracellular matrix degradingproteins
A constant remodeling of the extracellular matrix is needed at the growing tips of
the ureteric bud as it invades the metanephric mesenchyme during branching.
The major enzymes that degrade ECM and cell surface proteins are the matrix
metalloproteinase (MMP) family of secreted and membrane proteinases (Werb,
1997). MMPs are a large family of zinc requiring matrix-degrading enzymes
involved in physiologic and pathologic processes including invasive cell
behaviour in cancer and tissue morphogenesis in embryonic development
(reviewed in Sternlicht and Werb, 2001).
In the developing kidney (Ell), the metanephric mesenchyme is responsible for
the production of MMP-2 and MMP-9 (Lelongt et al., 1997). In organ culture,
addition of either a function blocking antibody to MMP-9 or exogenous tissue
inhibitor of metalloproteinase 1 (TIMP-1), the natural inhibitor of MMP-9,
resulted in impaired branching morphogenesis of the ureteric bud (Lelongt et al.,
1997).
MMP-2 is activated at the cell surface through an interaction with membrane-
type matrix metalloproteinase 1 (MT-l-MMP):TIMP-2 complex (Kanwar et al.,
1999; Sternlicht and Werb, 2001). In the developing mouse kidney, MT-l-MMP
is expressed at the ureteric bud epithelium (Ota et al., 1998). Inhibition ofMMP-
2 and MT-l-MMP with antisense oligodeoxynucleotides (ODN) resulted in
dysmorphogenesis of the ureteric bud with rudimentary branching and blunted
tips (Kanwar et al., 1999). Even though the MMP-2 inhibitor TIMP-2, is
synthesized by both the mesenchyme and epithelium in Er13 metanephroi, the
active TIMP-2 is found in the ureteric compartment (Barasch et al., 1999).
Immunohistochemical studies showed that TIMP-2 is localized in the condensed
mesenchyme surrounding the tips of the ureteric bud and in the ureteric bud
stalks and clefts (Barasch et al., 1999). Addition of exogenous TIMP-2 in rat
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metanephric cultures resulted in impaired branching morphogenesis and
enhanced deposition of collagen IV at areas that are usually devoid of collagen
IV, such as the tips of the branching epithelium (Barasch et al., 1999).
Intrinsic mechanisms of the branching epithelium
During branching morphogenesis the newly formed branches arise as
outpouchings of the epithelium, either by migration of a local region of
epithelium or by local, oriented cell divisions in some cases accompanied by
formation of a cleft in an existing branch (reviewed in Metzger and Krasnow,
1999).
The intrinsic mechanisms that are involved in the branching process during the
early kidney development have received little attention. Most of the research
during the early stages of kidney organogenesis has focused on the signals that
the ureteric bud receives from the metanephric mesenchyme and the signaling
pathways downstream of these signals (reviewed in Davies, 2001; Davies and
Davey, 1999).
The importance of efficient ureteric bud branching morphogenesis is a
requirement for correct nephron endowment and hence a fully functional kidney.
The work in my thesis focuses on the intrinsic mechanisms of ureteric bud
branching morphogenesis such as cell multiplication, cytoskeletal rearrangement
and differential gene expression that are important during embryonic
development and branching morphogenesis of other organs such as the lung,
salivary gland and Drosophila trachea (Goldin et al., 1984; Metzger and
Krasnow, 1999; Spooner, 1973).
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1.5 Aim of the thesis
With reference to the intrinsic mechanisms of epithelial development and using
the kidney organ culture as an experimental system, my aim was to investigate
whether cells in the active branching "tips" have specializations compared to the
rest of the ureteric bud epithelium.
The questions that my work aims to answer are the following:
1. Whether localized cell proliferation is a feature of the ureteric bud
branching morphogenesis and if this is the case, how it is regulated by
known branching promoting or inhibiting factors.
2. Whether the cytoskeleton has a special arrangement which correlates with
the branching activity and whether it is lost when branching
morphogenesis is arrested.
3. Whether there is a differential gene expression at the ureteric bud "tips"
when compared with gene expression at the stalks and whether this
difference is correlated with branching activity.
My findings underline the importance of the epithelium itself: it does not just
react from the influence of the mesenchyme but from its earliest stages it shows
specialization between of newly formed tips. These define the architecture of the





2.1 Culture of whole organs and Wolffian Ducts
2.1.1 Whole organs
Metanephric kidney rudiments were isolated from embryos of MF1 mice at
El 1.5 (morning of discovery of vaginal plug was taken to be E0.5). The
microdissections were performed with 0.5x16 mm needles (Terumo) in 35 mm
Petri dishes (CellStar) in Eagle's minimum essential medium with Earle's salts
(MEM; Sigma) which will be referred to as "dissecting medium". After isolation,
the kidneys were cultured for a set period of time according to the experiment on
5 pm isopore membrane filters (Millipore; Sigma) placed on Trowell screens in
culture medium (Davies, 1994) (figure 2.1). The culture medium used was
Eagle's MEM with Earle's salts from Sigma with non essential amino acids,
supplemented with 10% newborn calf serum (NCS; Labtech) and 5% antibiotics
(Penicillin/Streptomycin; Sigma) which will be referred to as "complete
medium". Experimental groups were cultured in the complete medium
supplemented with various reagents according to the experiment. Organs were
collected from either a single or two litters at the day of dissection and were
assigned randomly to control or treatment groups. All cultures were incubated in
a humidified atmosphere at 5% CO2 at temperature of 37°C. While the
development shown by controls was reasonably constant for a given run of an
experiment, there was sometimes variation between experiments done at
different times of year and with different batches of mice and media. Controls
and experimental samples were therefore compared within a run of an
experiment. They could only be compared between experiments when the
development shown by the two sets of controls could be shown to be not
significantly different.
2.1.2 Wolffian Ducts
Nephric ducts with their surrounding mesenchyme were isolated by
microdissection (as above) from El0.5 embryos which are too young to have
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Figure 2.1: Kidney organ culture
Kidneys isolated by microdissection from embryos (El 1.5), are placed
on polycarbonate filters on Trowell screens of stainless steel in culture
medium. Kidneys not to scale. (Courtesy of J.A. Davies.)
57
formed a ureteric bud. They were cultured for a time period according to the
experiment in complete medium (as described above).
2.2 Cell proliferation assay (chapter 3)
2.2.1 BrdU incorporation and experimental treatments
Cell proliferation was measured using 5-bromo-2'-deoxy-uridine (BrdU; Sigma)
which was added to the media at a final concentration of 100 pM for either a
time course of: 0-16, 16-32, 32-48 and 48-64 hours or for 24 hours prior to
fixation. In the case of the Wolffian ducts, BrdU was present for the total culture
period.
The experimental treatments were as follows: Whole kidney rudiments were
cultured for 48 hours in the presence of 30 mM sodium chlorate (AnaLaR,
BDH), an inhibitor of sulphated glycosaminoglycan synthesis, which blocks
ureteric bud branching in culture (Davies et al., 1995). Exogenous GDNF
(Sigma) was added to the cultures at the final concentration of 100 ng/ml for 24
hours and 48 hours. For local application of growth factor, Biorad Affigel Blue
beads were washed in dissecting medium for 30 minutes at 37°C, they were then
soaked in 1% bovine serum albumin (BSA) in PBS for the control and 50 pg/ml
GDNF (experimental) for further 30 minutes in 37°C. The beads were then
placed on one side of the T-stage El 1.5 kidney rudiments (as shown in figure
2.2) for 48 hours. Kidney rudiments were also cultured in 10 pg/ml anti-GDNF
(function blocking antibody from R&D systems) (Davies et al., 1999) for 48
hours. TGF-pi (Sigma) was added to the complete medium at final
concentrations of 1 nM for 24 or 72 hours.
Wolffian ducts were cultured for a time course of 4, 6, 8, 12 and 24 hours in






Figure 2.2: Local application of growth factor
Illustration showing the position of the control (1% BSA) or
GDNF-soaked beads, placed in close proximity to one of the
epithelial tips at the T-shape stage of an El 1.5 metanephric
kidney at the time of the dissection.
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duct in culture. Then Wolffian ducts were cultured for 6 and 8 hours in the
presence of 100 pM BrdU.
2.2.2 BrdU detection by whole mount immunofluorescence
The procedure followed was according to Davies et al. (Davies et al., 1995) with
some modifications. Cultured rudiments (whole kidneys and Wolffian ducts)
were fixed in methanol initially at -20°C and allowed to warm up towards room
temperature (RT) during the 10 minute period of fixation. Some were stored in -
20°C methanol until required. After fixation, kidneys (or Wolffian ducts) were
washed in PBS for 30 minutes then incubated in 4% paraformaldehyde (PFA;
BDH) for 30 minutes at RT. They were then washed in PBS, incubated in 0.5
mg/ml trypsin (Sigma) for 7 minutes at 37°C, refixed in 4% PFA for 1.5 hours at
room temperature and washed in PBS. To denature the DNA for BrdU detection,
rudiments were incubated in 95% formamide, 5% 0.15 M trisodium citrate
(BDH) for 1 hour at 70°C. They were washed in PBS for 30 minutes (RT) and
incubated at 4°C overnight in the presence of 1/200 anti-calbindin D28k
(Chemicon) or 1/100 anti-laminin (Sigma) and 1/50 anti-BrdU (mAb BU-33,
Sigma) in PBS. Samples were then washed for 30 minutes in PBS and incubated
in secondary antibodies overnight at 4°C. The secondary antibodies used were:
1/100 FITC or TRITC-conjugated anti-rabbit IgG (Sigma) and 1/100 TRITC or
FITC-conjugated anti-mouse IgG (Sigma) in PBS. After a last PBS wash
samples were mounted on slides and viewed on a Confocal Laser Scanning
Microscope (CLSM; LEICA TCS NT). For counterstaining of the nuclei,
monomeric cyanine nucleic acid stain TO-PRO-3 (Molecular Probes) was used
according to manufacturer's instructions (1 pM TO-PRO-3 in dimethylsulfoxide
(DMSO) for 5 minutes followed by another PBS wash) and then kidneys were
mounted on slides before scanning on the CLSM.
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2.3 Cytoskeleton experiments (chapter 4)
2.3.1 Experimental treatments
Whole kidney rudiments were cultured under control conditions in complete
medium for a time course of 24, 48 and 72 hours. Kidneys were also cultured for
48 hours in the presence of 30 mM sodium chlorate to block ureteric bud
branching as described before (Davies et al., 1995). Kidneys were cultured in the
presence of 10 pM 2'amino-3'-methoxyflavone (PD98059; Calbiochem) in
DMSO for 72 hours as described in Fisher et al. (Fisher et al., 2001).
Cytochalasin D (Cyto D; Sigma), a specific inhibitor of filamentous actin
formation (Sampath and Pollard, 1991), was added in the culture medium at the
beginning of the incubation period at concentrations 0.5, 0.3 and 0.1 pg/ml from
a stock of 1 mg/ml in DMSO. In controls, DMSO was added at 0.05%, 0.03%
and 0.001%. All organs were cultured for 72 hours in the above concentrations.
The lowest concentration (0.1 pg/ml) was also used in cultures incubated for a
time course of 24, 48 and 72 hours. To verify that the effect of the lowest
concentration of cytochalasin D used was reversible the kidneys were cultured in
the presence of 0.1 pg/ml cytochalasin D and 0.001% DMSO (control) for 24
hours and then transferred to complete medium alone for 24 hours. Kidneys were
also cultured in four different conditions; (i) in the presence of 0.001% DMSO
(control), (ii) Cyto D alone (0.1 pg/ml), (iii) 30 mM sodium chlorate alone and
(iv) 0.1 pg/ml Cyto D with 30 mM sodium chlorate for 72 hours.
For the adherens junction experiments, kidney rudiments were cultured in the
presence of 0.1 pg/ml cytochalasin D and were immunostained (as described
below) for anti-E-cadherin.
A potent inhibitor of myosin 2,3 bunetadione monoxime (BDM; Calbiochem)
(Cramer and Mitchison, 1995; Herrmann et al., 1992) was used at the
concentrations of 5 mM, 10 mM, 20 mM for 72 hours. For reversibility
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experiments, 5 mM BDM was included in the cultures for 24 hours and then the
medium was changed to complete MEM for further 24 and 48 hours
El0.5 Wolffian ducts were cultured in complete medium for 12 hours.
2.3.2 Immunofluorescence
For F-actin localization experiments, the organs were fixed in 4% PFA for 2
hours at room temperature and washed in PBS supplemented with 1% Triton-X
100 (Sigma) for 30 minutes. They were then stained for actin by incubating them
overnight at 4°C using 1/100 TRITC-conjugated phalloidin (Sigma) in PBS (20
pg/ml stock concentration) (Cooper, 1987). There was a final rinse in PBS for an
hour and the organs were mounted on slides to be examined on the CLSM.
For the double staining experiments, organs were incubated following the wash
step in PBS/ 1% Triton-X 100, in primary antibody (1/100 anti-laminin or 1/200
anti-calbindin D28k in PBS) overnight at 4°C. They were then washed in PBS for
30 minutes and further incubated in the presence of 1/100 FITC-conjugated anti-
rabbit IgG and 1/100 TRITC-Phalloidin in PBS.
For adherens junctions immunolocalization, kidneys were fixed in -20°C
methanol, washed for 30 minutes in PBS (RT) and incubated overnight (at 4°C)
in 1/100 anti-laminin and 1/100 anti-E-cadherin (DECMA; Sigma) antibodies.
They were then washed in PBS and further incubated (at 4°C) in 1/100 TRITC-
anti rabbit IgG and 1/100 FITC-anti rat IgG.
For BDM experiments, the kidneys were fixed in -20°C methanol and
immunostained for FITC-anti-calbindin D28k
All samples were washed in PBS (30 minutes at RT) before mounting on slides
and examining on the CLSM.
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2.4 Lectin binding assay (chapter 5)
2.4.1 Experimental treatments
Isolated whole kidneys were cultured for 24, 48 and 72 hours at 37°C. GDNF
(100 ng/ml) was added to the medium and kidneys were cultured for 48 hours.
Function blocking anti-GDNF (10 pg/ml) was added to the culture for 48 hours.
2.4.2 Organ recombination experiments
El 1.5 whole kidney rudiments were microdissected as described in section 2.1.
Kidneys at the time of dissection were at the T-shape stage (a stalk and two tips
180° apart). One ureteric bud tip was removed by dissection from each whole
kidney (figure 2.3A). The remaining T-shaped ureteric bud epithelium was
transferred into a new culture petri dish and isolated metanephric mesenchyme
from other whole kidneys was placed in contact with the missing end of the
epithelium (figure 2.3B). The technique described is shown in figure 2.3. The
control kidneys were cultured for 24 hours and the T-shaped ureteric buds were
cultured for 48 hours.
2.4.3 Lectin Histochemistry
Kidney rudiments were fixed in ice cold methanol (-20°C) for 10 minutes or kept
at -20°C until required. They were washed in PBS for 30 minutes and incubated
at 4°C overnight in primary antibody (for the experiments using whole organs:
1/100 anti-laminin, for the experiments of T-shaped ureteric buds: 1/200 anti-
calbindin D28k in PBS). After 30 minutes wash in PBS, they were then
incubated in secondary antibody (1/100 TRITC-anti rabbit IgG in PBS) and
1/100 FITC-conjugated Dolichos Biflorus Agglutinin (FITC-DBA; Sigma)
overnight at 4°C. After a last 30 minutes wash in PBS they were mounted on











Figure 2.3: Schematic representation of organ recombinations
(A) shows an El 1.5 kidney (ureteric bud at T-shape stage) after
microdissection. The arrow shows where the ureteric bud (UB) tip is
separated from the rest of the kidney (B) shows the remaining of the T-
shaped ureteric bud surrounded by new metanephric mesenchyme (MM)
obtained from other El 1.5 metanephroi.
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2.5 Differential display (chapter 5)
Kidney rudiments were isolated by microdissection from embryos of MF1 mice
at El 1.5 as described in section 2.1.1. After isolation, the stalks and tips were
further microdissected as shown in figure 2.4. Stalks and tips were frozen at -
70°C until RNA preparation. A total of 20 stalks and 20 tips were isolated.
Total RNA was extracted from the isolated tips and stalks using the RNeasy Mini
Kit from Qiagen (cat. No. 74104) according to the manufacturer's instructions;
the isolated tips and stalks were lysed in the presence of a highly denaturing
guanidinium isothiocyanate containing buffer which inactivates RNases and
ensures isolation of intact RNA. The samples were homogenized using a syringe
and needle, each lysate was centrifuged and 70% ethanol was added to the
supernatant to provide appropriate binding conditions and the samples were
applied to RNeasy mini spin columns where the total RNA binds to a silica-gel-
based membrane. To eliminate possible DNA contamination an RNase-free
DNase Set from Qiagen was used (cat. No. 79254) following manufacturer's
instructions. Total RNA was eluted in RNase-free water.
The quality of RNA was evaluated by 1% agarose (Sigma) gel electrophoresis.
Agarose gel (1%) was made using 0.5 g agarose in 50 ml lx TRIS-BORATE-
EDTA (TBE; Sigma) buffer. Samples were run for 30 minutes at 80 V.
For cDNA synthesis approximately 2 pg total RNA of each sample were used.
Reactions contained 3.33 pM of each anchored primers 5'- TTT TTT TTT TTT
VG-3', 5'- TTT TTT TTT TTT VA-3', 5'- TTT TTT TTT TTT VC-3' (V: A, G,
C; MWG-Biotech), PCR buffer (xl0)(lnvitrogen), 3 mM MgCE (Invitrogen), 0.5
mM dNTPs (Invitrogen) and 12 Units/pl RNAse inhibitor (Invitrogen) in 15 pi
RT-reaction mixture for first-strand cDNA synthesis with Moloney murine












Figure 2.4: Tip vs. stalk microdissection
Illustration of the dissection steps for the isolation of differentially expressed
genes at the branching epithelium. The tips and stalks were mechanically
removed by microdissection from El 1.5 metanephroi at the T-shape stage of the
ureteric bud.
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Reactions were incubated at 42°C for 1 hour and heated to 95°C for 5 minutes to
inactivate reverse transcriptase.
Each differential display PCR reaction contained lx PCR buffer, 2 pM dNTPs,
352.5 pM of one of three anchor primers, 1000 Ci/mmol S dATP (Amersham),
0.075 units/pl Taq polymerase (Promega), 1 pi cDNA from previous step and 0.5
pM of one of arbitrary primers in a total volume of 20 pi. PCR reactions were
performed with a Hybaid Omnigene cycler. The cycling parameters were as
follows: 94°C for 2 minutes (1 cycle; denaturation), 94°C for 30 seconds 40°C
for 2 minutes 72°C for 30 seconds (40 cycles) and 72°C for 5 minutes (1 cycle;
extension). Sequences of the 5' arbitrary primers were as follows: PI: 5'- GGA
ACC ATT C-3', P2: 5'-ACA GAG CAC A-3', P3: 5'- ACG TAT CCA G-3', P4:
5'- CTT TCT ACC C-3' (MWG 527835-1).
Samples were separated in a 6% polyacrylamide/ 7 M urea DNA sequencing gel.
[For lx gel was made as follows: 23 g urea (Sigma), 10 ml 5x TBE buffer, 7.5
ml 40% Acrylamide/Bis 19:1 solution (Biorad), 6 pi 10% sodium dodecyl sulfate
(SDS; Biorad) up to 50 ml of distilled water. Last 400 pi 10% ammonium
persulfate (APS; Sigma) and 70 pi N,N,N',N'- tetramethylethelenediamine
(TEMED; Biorad) were added.]
Loading dye (3.3 pi of 80% formamide, 0.01% bromophenol blue (Sigma),
0.01% xylene cyanol (Sigma), 1 mM EDTA (Sigma), 10 mM sodium hydroxide)
was added to each tube which were heated for 30 minutes at 100°C and 6 pi of
each sample were loaded on the 6% polyacrylamide gel. The gel was pre-
warmed for 1 hour at 1.5 kV before samples were run for 3.5 hours at 1.5 kV.
The gel was fixed (in 10% methanol and 10% acetic acid), transferred to blotting
paper (3 MM; Whatmann), dried overnight and exposed overnight to 35x43 cm
Kodak scientific imaging film (Sigma).
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2.6 Confocal microscopy and image analysis
The samples were examined on the TCS NT Leica confocal laser scanning
microscope (Leica Microsystems Heidelburg, GmbH, Germany). For dual-
labeled samples, both FITC and TRITC emissions were acquired simultaneously,
once appropriate checks had been carried out for any cross-talk between the
channels. For all experiments, the pinhole was adjusted to 1.00 before scanning
and other critical settings were maintained the same for both experimental and
control groups. Serial optical sections of each kidney were acquired with the xlO
objective for whole kidney morphology and branching quantification, the x20
objective for tip morphology and nuclei counting, and the x40 (or digitally
zoomed by a factor of 2) for specific tip morphology. For the Wolffian ducts, an
initial x5 magnification was used to capture the whole nephric duct and then
serial, optical sections of the metanephric area were obtained at a higher
magnification (x20).
In chapter 3, the x20 lens was used (unless otherwise stated), in order to have a
clearer view of the BrdU positive nuclei along the ureteric bud tips and stalks.
For serial optical sections, the top and bottom scanning points were selected. The
thickness of each section was user defined at 3 pm. The Leica software
automatically calculated and adjusted the step size (thickness) in a range of ±
0.300 pm in order to best fit in the selected region.
In chapter 4, optical sections of the tips were obtained at the x20 and x40
objective.
The software packages used for the analysis (chapter 3) were Adobe Photoshop
(version 5.0) and Scion Image (version beta 4.0.2) downloaded as a freeware
from the world wide web (http://www.scioncorp.com).
P values were calculated using the Student's two sample t-test assuming
independent measurements and allowing, when necessary, for different values of
n in control and experimental groups (Owen and Jones, 1994). Calculations were
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performed using Microsoft Excel. Differences were assumed to be significant at
p<0.05. For quantification of BrdU incorporation, n values represent the number
of tips for each independent measurement, while for quantification of branching
n values represent the number of kidneys in each sample.
The experiments presented in chapter 3 were not all performed the same number
of times due to technical difficulties.
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Chapter 3
Involvement of Localized Cell Proliferation in Ureteric Bud
Branching Morphogenesis
3.1 Introduction
3.1.1 Localized cell proliferation during embryonic development
Embryonic morphogenesis and organogenesis are the result of a coordination
between the driving forces of morphogenesis and the processes of cell growth,
proliferation, differentiation and death (Hogan, 1999). During development, the
epithelia of the embryo change shape as they fold into tubes, spheres or pockets
as well as during bud evaginations. It has been argued that cell proliferation
contributes to these shape changes (for review see Huang and Ingber, 1999).
There is evidence from a number of systems that differential cell proliferation
correlates with morphogenesis. For example in the case of thyroid gland
organogenesis (figure 3.1), there is an increase in cell number during the period
when morphogenetic shape changes. While the gland evaginates from the floor
of the pharynx, high cell proliferation is found in the adjacent pharyngeal cells.
Differential growth combined with the mechanical forces resulting from the
pressure of the increased cell numbers, leads to the evagination of the gland
(Smuts et al., 1978).
Morphogenesis of the tooth (figure 3.1) involves epithelial-mesenchymal
interactions (reviewed in Jernvall and Thesleff, 2000). Thickening of the oral
epithelium to form the tooth bud is the initial sign of tooth development
surrounded by condensed mesenchymal cells. In mammals, tooth development
progresses as the epithelium undergoes folding morphogenesis (Thesleff and
Jernvall, 1997). Members of the fibroblast growth factor family (FGF-4, -9, -10),
expressed by the enamel knot cells in the dental epithelium and the mesenchyme,
are considered key signals that regulate the growth and folding of the epithelium.
Rapid proliferation of epithelial cells around the enamel knot is thought to
account for the folding of the epithelium at the sites of the tips of future tooth













(From Thesleff and Jernvall, 1997)
Figure 3.1: Folding morphogenesis
(A) Development of chick thyroid gland (stages 17 to 30) and
(B) stages in development of the tooth
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3.1.2 Localized cell proliferation during branching morphogenesis
During branching morphogenesis, where an epithelium evaginates as a bud,
elongates and undergoes subdivisions of the terminal branches, localized cell
proliferation is one of the factors contributing to the formation of the tree-like
structure. This is the case in mammary gland, where the end buds are bulbous
and highly mitotic (Daniel et al., 1984). The terminal end buds of the pubertal
and postpubertal mammary glands in culture show increased DNA synthesis, in
contrast to the duct epithelium (Bresciani, 1968). Also in the developing lung,
there is evidence that implicate localized intense cell proliferation in bud
formation (Goldin et al., 1984). In the inactive epithelial regions between lung
buds the level of cell proliferation is lower than in the growing tips of the
actively branching buds (Goldin and Opperman, 1980).
In contrast, the Drosophila tracheal system is a branching network that forms
without cell proliferation. As described in chapter 1, the tracheal system is
formed as ten placodes on each side of the embryo. Each placode is composed of
approximately twenty cells with the number of cells reaching approximately 80
after two rounds of division. The dramatic growth of the respiratory network
takes place from this finite number. The last tracheal cell division occurs just
before primary branching begins. Therefore, the total number of tracheal cells
does not increase as the primary branches grow (Samakovlis et al., 1996). The
new branches are formed by migration and rearrangement of tracheal cells and
by cell elongation. Each secondary branch is formed by a single tracheal cell
(Samakovlis et al., 1996).
Aim
The aim of this chapter is to develop a technique to measure proliferation in
cultured kidney rudiments and, using this technique, to establish whether (i)
differential cell proliferation is present during ureteric bud branching in culture;
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(ii) differential cell proliferation is present during ureteric bud outgrowth, and
(iii) whether two known regulators of UB branching affect cell proliferation in
the epithelium.
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3.2 Development of a quantification method for measuring
cell proliferation
In order to establish a technique to evaluate as objectively as possible the
proliferating cells at the tips of the ureteric buds, the analysis was categorised
into three distinct groups (sections 3.2.1, 3.2.2, 3.2.3 respectively) according to
the effect that the experimental treatments have on the branching of the
epithelium.
3.2.1 Quantification of proliferating nuclei along the branching
ureteric bud epithelium and the Wolffian duct
Stacks of three middle optical sections (each of 3 pm thickness) were selected
from the original confocal files, where the tips marked out for analysis were at
their widest planes. All the stacks were the overlay of green and red channels.
We have described the quantification method used in Fisher et al., (Fisher et al.,
2001). Using Adobe Photoshop, three successive lines of 100 pm were drawn
across the ureteric bud tubules starting from the terminal tip edge towards the
stalk. These lines divided the tubule into 100 pm long segments. In the case of
Wolffian ducts, the lines started from the caudal tip of the duct and continued
towards the mesonephros (see section 3.3.3). The BrdU positive nuclei, in each
segment, were then counted (manually).
3.2.2 Quantification of proliferating nuclei at ureteric bud tips
where experimental treatments affected the tip morphology
Some experimental treatments used affected the morphology of the branching
epithelium. For the purposes of the analysis, there was a need to define what is a
"tip". Since an antibody specific for "tip" was not available and in situ
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hybridization is not compatible with BrdU staining the area considered as the
"tip" was based on the morphology of the branching epithelium and was
separated in two groups:
- The first definition of the "tip" was chosen on the basis of the
branching pattern of the control ureteric buds. In control kidneys the swelling
of the ureteric bud stalk tube to form the ampulla was considered the
beginning of a tip. In the experimental groups, the presence of a swelling of
the branch tube towards the end of the branch was considered to be the
beginning of a tip.
- For the second definition, a line was drawn (as described in
section 3.2.1) across a well-defined control ampullary tip from the outer edge
towards the stalk. The length of this line was measured by the software and
was used to define the terminal part of all the branches (tips) of the groups
(control and experimental) of each experiment.
In order to develop the most objective quantification method to use, a number of
possible methods was applied on one experimental set. These methods are
described below. They are categorized according to the previously mentioned
"tip" definitions (methods I-IV and methods V-VIII), measurements performed
on single optical sections or stacks and thresholding and their results are
compared (see results section).
Method I (single sections)
Single original optical sections (overlay of red and green channels) were
imported to the Scion Image program. All the optical sections were calibrated to
the appropriate scale (500 pm2) as all the original optical sections were scanned
at x20 objective. Using the free hand tool to draw round the tip, the tip area was
j • 2measured in pm . The single optical section chosen was the one where the tip
was at its widest plane. The BrdU positive nuclei inside the selected area were
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then counted (manually). The proliferating nuclei measured were subsequently
2
expressed as the number of BrdU positive per 1000 pm of epithelium.
Method II (stacks)
From the gallery of the original optical sections of each metanephros, three
middle sections (where each tip was at its widest plane) were selected and were
saved as stacks (overlay of green and red channels). The stacks were then
imported to Scion Image and the area of each tip was measured as above. The
BrdU positive nuclei inside that area were then counted.
Method III (single sections, threshold)
In order to minimize the possible experimenter's bias on the selection of the
positive nuclei present, a user defined adjustment of the fluorescence background
threshold was applied. The single optical sections used for method I were
imported in Scion Image and converted into gray scale images. The threshold
value was taken as three times higher than the mean background value plus the
standard deviation of the selected area. Anything above this value was
considered as a BrdU positive nucleus.
The tip area was measured in pm as described in method I. The BrdU positive
nuclei inside the measured tip area were counted.
Method IV (stacks, threshold)
The stack sections were imported to Scion Image and were converted into gray
scale images. A random area was selected within each tip and the background
intensity was measured. The background threshold was adjusted as previously
described and the BrdU positive nuclei were counted inside the tip (the tip area
was measured in pm ) as in method III.
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Method V (single sections, Xpm length)
For this method onwards, the second definition of the "tip" was applied. A
specific length from the edge of a control tip was selected and was used in all the
tips (control and experimental) of each experiment to be analysed. The choice of
the applied length was made upon measuring an average sized and well-
structured control tip. This selection was made anew for each experiment.
The single optical sections were again employed; the new terminal tip areas were
highlighted and measured in pm2; the BrdU positive nuclei inside this area were
counted (manually).
Method VI (stacks, Xpm length)
This method is a combination of methods II and V. Stacks of the optical sections
were imported in Scion Image. The terminal tip areas were measured by the
software as in method V (in pm2) and the BrdU positive nuclei in the selected
areas were counted (manually).
Method VII (single sections, Xpm length, threshold)
This method is a combination of methods III and V. Essentially, the single
optical sections where the tips were at their widest planes were selected and
converted into gray scale images. The terminal tip area was measured as in
method V, the background threshold was adjusted as previously described and
the BrdU positive nuclei were counted as in method III.
Method VIII (stacks, Xpm length, threshold)
This method is a combination of methods IV and VI. In brief, the stacks of
optical sections were converted into gray scale images. The terminal tip area was
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selected as described in method V. The background threshold was adjusted and
the BrdU positive nuclei were counted as described in method III.
3.2.3 Quantification of BrdU positive nuclei where the treatment
affects ureteric bud branching resulting in identifiable tip
morphology
In the experiments where treatment affected branching morphogenesis, leaving
the morphology of the terminal tips still identifiable, counting method IV was
used on stacked optical sections.
The stacks were selected from the gallery of the original files, they were
imported to Scion Image and they were converted into gray scale images. The tip
area was highlighted and measured in pm2, the background threshold was
adjusted as described in method III and the BrdU positive nuclei were counted
manually. Then, they were expressed as a number of BrdU positive nuclei per
1000 pm2 of epithelium.
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3.3 Results
The hypothesis that differential cell proliferation is a feature of the ureteric bud
tip during branching morphogenesis of the developing epithelium was tested by
bromodeoxyuridine incorporation in cultured kidney rudiments.
3.3.1 BrdU incorporation and labeling index
To measure the levels of proliferation, I initially planned to use the nuclear
labeling index (percentage of BrdU positive nuclei/100 nuclei) (Nadasdy et al.,
1998). The kidneys grown for 24 hours in BrdU were subsequently
immunostained with either anti-calbindin D28k, a specific marker for ureteric
bud and developing collecting duct (Davies, 1994), or with anti-laminin which
stains the basement membranes and is widely used by our laboratory (Davies et
al., 1995). For the nuclear labeling index, proliferating and non-proliferating
nuclei were counterstained (figure 3.2) using a monoclonal antibody to BrdU
(Davies et al., 1995) and a monomelic cyanine nucleic acid stain (T0-PR03)
suited for the Leica confocal microscope (L. Sharp, personal communication).
There was an intense nuclear staining of the mesenchymal component, whereas
in the deeper layers where the epithelium is present the staining was much
weaker and the fluorescence faded rapidly even in the presence of an anti-fading
agent. Because of this, the counterstaining of the nuclei on the epithelium was
not efficient for quantification using the nuclear labeling index (figure 3.2). It
was therefore necessary to develop an alternative method to measure the BrdU
incorporation in the whole mount ureteric buds.
The development of the quantification techniques used for the analysis of the
experiments was described in the previous paragraph (see section 3.2). To
measure the proliferation, I could not use the number of BrdU positive nuclei per
100 nuclei, therefore I measured cell proliferation as the BrdU positive nuclei per













Figure 3.2: Staining of proliferating and non-proliferating
nuclei at the tip of the ureteric bud
Ureteric bud terminal tips triple-stained with (A) FITC- anti calbindin
D28k, (B) TRITC- anti BrdU, (C) T0-PR03. Panel (D) shows the
merged confocal image of anti-BrdU and T0-PR03. Arrows showing
the BrdU positive nuclei on the epithelium. UB: ureteric bud, MM:
metanephric mesenchyme, t: terminal tip. Scale bars =100 pm.
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Some of the experimental treatments used affected the ureteric bud branching
morphology. In these cases, the hypothesis was to investigate the effect that a
negative modulator of branching would have on the cell proliferation in the
epithelial tip. However, it was not possible to distinguish with certainty the
borderline between the stalk and the tip. Therefore, I had to decide what to
consider as a "tip" under my experimental conditions. For this reason, I used the
two previously mentioned definitions (see section 3.2) which are both based on
the morphology of the control tips. In the first, a swelling of the stalk tube toward
the end of the branch is considered a "tip", whereas the second is based on a
specific length (based on a well-defined control tip) drawn from the end of the
branch and considers that area as the "tip". In order to establish the proper
method to apply I used one experiment as model.
In this model experiment, in order to count the proliferation I used either single
sections (3 pm thickness) where the "tip" was at its widest plane or stacks of
three optical sections (of 3 pm thickness each). The stacks were composed of the
single optical section where the "tip" was at its widest plane, ± an optical section
above and below in order to include possible nuclei that might have been missed
in the single optical sections. All stack measurements showed a higher average of
nuclei present in controls and a variation on the experimentals. This did not
affect the difference between control vs. experimental in a single method
(compare I-II, III-IV, V-VI, VII-VIII in figure 3.3). For the following
experiments, I used the stacks for the analysis.
In order to minimize a possible bias to whether a bright fluorescent "spot" is a
positive BrdU nucleus, I adjusted the threshold to 3x higher than background and
anything above this value was considered to be a positive nucleus. This resulted
in a reduction in difference between control and experimental in the methods
using the threshold without affecting the statistical significance (compare






































Method Method Method Method Method Method Method Method
I II III IV V VI VII VIII
Figure 3.3: Development of the quantification method for
measuring cell proliferation
Comparison of counting methods I-VIII. The average number of BrdU
positive nuclei per 1000 jam2 of tissue were measured. Control n= 38,
chlorate n= 5 (n values represent the number of tips). Data are shown as mean








control: 1.28 ±0.15, chlorate: 0.39 ±0.15, p= 0.0008
control: 1.63 ±0.19, chlorate: 0.29 ±0.12, p= 2.22 xlO"6
control: 0.57 ± 0.08, chlorate: 0.26 ± 0.08, p= 0.015
control: 1.05 ± 0.13, chlorate: 0.41 ± 0.20, p= 0.024
control: 1.13 ± 0.15, chlorate: 0.72 ± 0.35, p= 0.32
control: 1.53 ±0.17, chlorate: 0.53 ± 0.25, p= 0.009
control: 0.91 ± 0.13, chlorate: 0.52 ± 0.31, p= 0.28
For method VIII, control: 1.28 ± 0.16, chlorate: 0.58 ± 0.16, p= 0.008
(the methods are described in section 3.2.2)
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All methods showed variations among them, but they all showed statistically
significant difference between control and experimental treatment. The only
exceptions are method V and VII that use the single optical sections using the
second "tip" definition, where the experimental group shows a greater standard
error. These methods were not used further.
Overall, as the majority of the methods showed statistically significant
difference, for the subsequent experiments the stack sections combined with
thresholding (method IV) was used as the most objective method of
measurement. In the experiments where the tip morphology was ambiguous, the
quantification was performed using both "tip" definitions (i.e. methods IV and
VIII).
Quantification of the results of all methods is shown in figure 3.3.
3.3.2 Localized cell proliferation is confined at the tips of ureteric
bud branching epithelium
To examine whether there is regional variation in levels of BrdU incorporation
during branching morphogenesis in culture, El 1.5 isolated metanephroi were
cultured over a time course of zero to 64 hours (figure 3.4). Cell proliferation
(BrdU positive nuclei per unit length) was measured on the ureteric bud branches
for the culture period of 16-32 hours, by the method described in section 3.2.1.
More proliferating nuclei were localized at the first 100 pm (figure 3.5), a
distance that for the particular experiment defined the tip, than in the stalk behind
it. The mean number of BrdU positive nuclei at the tip (0-100 pm) was 12.1 ±
1.60. The subsequent 100 pm (distance 100-200 pm) defined the stalk
immediately away from the tip. The average number of BrdU positive nuclei was
3.47 ± 0.67 and at the subsequent 100 pm of stalk further away from the tip (that
is 200-300 pm) the average number of proliferating nuclei was 3.50 ± 1.05. The
data are expressed as the mean ± standard error of the mean.
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Figure 3.4: Cell proliferation during ureteric bud branching
morphogenesis
BrdU incorporation (100 pM) for 16 hours in kidney rudiments cultured
at time intervals of 0-16 hours (A), 16-32 hours (B), 32-48 hours (C) and
48-64 hours (D). Arrows show the BrdU positive nuclei at the tips of the
branching epithelium. Double staining: FITC-anti laminin and TRITC-
anti BrdU. UB: ureteric bud. MM: metanephric mesenchyme, t: terminal



























Distance from tip end (in jim)
Figure 3.5: Cell proliferation is confined to the
ureteric bud tips during branching morphogenesis
BrdU (100 |j,M) was incorporated for the last 16 hours of 32
hours culture of El 1.5 kidney rudiments. BrdU positive nuclei
were counted along the ureteric bud at 100pm distance from
the tip edge towards the stalk (0-100 pm= tip, 100-200 pm and
200-300 pm= stalk). Data are shown as the mean ± SEM.
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These results suggest that there is a local increase in proliferation concentrated at
the tips. This difference in local proliferation may be a driving force for the
branching pattern of the developing ureteric bud.
3.3.3 Localized cell proliferation is the first sign of ureteric bud
outgrowth from the Wolffian duct
Since branching activity is accompanied by localization of cell proliferation at
the ureteric bud tips, one could wonder whether localized proliferation precedes
the formation of the first tip, the ureteric bud itself. In order to test this
hypothesis, BrdU was incorporated in Wolffian ducts at the stage prior to the
emergence of the ureteric bud.
The timing of the ureteric bud outgrowth from the nephric duct in culture was
established by a time course. El0.5 Wolffian ducts were cultured for 4, 6, 8, 12
and 24 hours (figure 3.6). By 24 hours the ureteric bud had already branched
(figure 3.7). The timing of ureteric bud emergence in culture was found to be at
around eight hours. BrdU incorporation was quantified along the Wolffian duct
(as described in section 3.2.1). Consecutive distances of 100 pm were selected at
both the metanephric area (seven lines of 100 pm) and further up the duct
towards the mesonephros (nine lines of 100 pm). The average number of the
BrdU positive nuclei per 1000 pm was measured along these lengths. The
results shown in figure 3.8 support the hypothesis that at the presumptive
metanephric area there is an area of increased localized cell proliferation where
the ureteric bud will evaginate. At a randomly selected area on the nephric duct
towards the mesonephros, the cell proliferation at the selected distances
measured does not show a specialized pattern (figure 3.8 B).
This result suggests that localized cell proliferation in vitro, may be one of the












Figure 3.6: Wolffian Ducts in culture
A Wolffian Duct in culture for a time course of (A) 4 hours, (B) 6 hours,
(C) 8 hours and (D) 12 hours. Open arrows point towards the location of
the mesonephros. Staining: FITC-anti calbindin D28k. WD: Wolffian
duct, UB: ureteric bud. Scale bar = 100 pm.
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Figure 3.7: Wolffian Duct in culture for 24 hours
A Wolffian Duct in culture for 24 hours. Dashed arrows show the
branching ureteric bud, open arrow points towards the location of the
mesonephros. Staining: FITC-anti laminin. WD: Wolffian duct, UB:
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3.3.4 Localized proliferation is reduced when branching is blocked
In order to test whether the higher proliferation rate observed at the tips is
present only during the formation of new branches, branching was arrested and
BrdU incorporation was examined.
El 1.5 kidney rudiments were cultured in 30 mM of sodium chlorate, a specific
sulphation inhibitor which inhibits the synthesis of sulphated
glycosaminoglycans, hence blocking ureteric bud development (Davies et al.,
1995). The control tree-like branching pattern of the collecting duct is distorted
in kidneys growing in chlorate. It has been reported that this reduction of
branching is accompanied by inhibition of cell cycling (Davies et al., 1995).
However, it is not known whether the fewer cells still proliferating are confined
to the tips.
The morphology of the ureteric buds treated with sodium chlorate changes
dramatically from the controls. Cell proliferation appears reduced in the kidneys
cultured in chlorate (figure 3.9). BrdU incorporation was quantified at the tips of
the ureteric buds cultured in chlorate in comparison to control kidneys (figure
3.10). The branching of the chlorate treated kidneys is reduced, but the size of
the tips is larger than the size of the control tips. The average size of the control
tips was 4570.2 ± 250.3 pm in comparison to the average size of the chlorate
tips of 10077.5 ± 1212.9 pm2. Quantification (by method IV) revealed that the
average number of BrdU positive nuclei per 1000 pm2 of epithelium at the tip
was 1.05 ±0.13 for the control tips and 0.41 ± 0.20 for the chlorate tips. This
difference is significant at p= 0.02. Measuring cell proliferation by method VIII,
the average number of BrdU positive nuclei per 1000 pm2 of epithelium at the
control tips was 1.28 ± 0.16 and 0.46 ± 0.16 for the chlorate tips (p= 0.008). Both
methods are performed on stack sections, using fluorescent background
91
Figure 3.9: Effect of sodium chlorate on cell proliferation at
the ureteric bud tips
(A) Control El 1.5 kidney in culture for 48 hours, (B) El 1.5 kidney in
culture supplemented with 30 mM sodium chlorate. Arrows showing
BrdU positive nuclei at the tips of the ureteric bud. Double staining:
FITC-anti laminin and TRITC-anti BrdU. UB: ureteric bud, MM:
metanephric mesenchyme, t: terminal tip. Scale bars = 100 pm.
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Figure 3.10: Blocking branching results in a reduction of cell
proliferation at the tips of the ureteric bud
Quantification methods IV and VIII show a significant difference in cell
proliferating at the ureteric bud tips between control and 30 mM sodium
chlorate treated kidneys. Data are shown as the mean of BrdU positive
nuclei per 1000 pm2 of epithelial tip (control (IV): 1.05 ± 0.13, chlorate
(IV): 0.41 ± 0.20, control (VIII): 1.28 ± 0.16, chlorate (VIII): 0.58 ±
0.16). Control n= 38, chlorate n= 5 (n values represent the number of
tips). Error bars are the SEM, p= 0.02 (IV), p= 0.008 (VIII).
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thresholding and differ only in the definition of the tip. Method IV uses the first
definition of the tip, whereas method VIII uses the second definition.
These results support the hypothesis that when the ureteric epithelium is not
actively branching, the cell proliferation at the bud tips is significantly reduced,
that is local proliferation is a feature of active tips.
3.3.5 GDNF effect on cell proliferation at the ureteric bud tips
GDNF is a major paracrine factor involved in metanephric development that
binds to the ureteric bud tips (Sainio et al., 1997b). Here, the aim is to test the
hypothesis that GDNF branch-promoting effect might be due to increased cell
proliferation at the ureteric bud tips. In order to test this, GDNF was (i) added to
the kidney cultures generally and (ii) applied locally on a bead, and BrdU
incorporation was quantified at the tips of the branching epithelium.
When applied to culture medium, GDNF (100 ng/ml) did not result in an
increase of the number of tips, but rather in an abnormal morphology of the
epithelium with distorted branching pattern. The average number of the tips in
control kidneys was 7.83 ± 1.35, whereas in GDNF treated kidneys it was 5.00 ±
0.24 (p= 0.09). There was an enlargement of the tips and ectopic tips emerged
from the stalks (figure 3.11). The average size of the GDNF treated tips (referred
to as "major" tips) was larger (2.6 xlO4 pm2) than the average size of control tips
(4.8 xlO3 pm2). The ectopic tips (5.4 xlO3 pm2) were also larger than the control
tips. The question is whether this "swollen" morphology of the tips and the
presence of the ectopic tips occurs as a result of an increase in the cell
proliferation. Quantification of the BrdU incorporation was performed as
described in section 3.2.3. The average number of BrdU positive nuclei per 1000
pm2 in control tips was found to be: 4.91 ± 0.58, in GDNF "major" tips: 3.89 ±
0.55 and in GDNF ectopic tips: 3.13 ± 0.43. There was no significant difference
in the cell proliferation between control and GDNF "major" tips (p= 0.38)
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Control tips GDNF tips GDNF ectopic tips
Figure 3.11: GDNF effect on cell proliferation
(A) control kidney in culture for 48 hours, (B) kidney culture
supplemented with 100 ng/ml GDNF for 48 hours. Arrows showing the
BrdU positive nuclei on the epithelium, yellow arrows show the ectopic
tips. Double staining: TRITC-anti calbindin D28k and FITC-anti BrdU.
(C) Average number of BrdU positive nuclei per 1000 pm2 at the tips of
the epithelium (control : 4.91 ± 0.58, GDNF: 3.89 ± 0.55, GDNF
ectopic: 3.13 ± 0.43). Control n= 35, GDNF n= 29, GDNF ectopic n= 20
(n values represent the number of tips). Data are shown as mean ± SEM.
UB: ureteric bud. MM: metanephric mesenchyme. Scale bars = 100 pm.
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control tips (p= 0.02 <0.05). These results suggest that exogenous GDNF does
not exert a mitogenic effect on ureteric bud epithelial tips in culture.
A GDNF soaked bead was locally applied adjacent to the tips of T-shape stage
El 1.5 ureteric buds. The effect of the local application of GDNF on the tip
morphology was similar to the exogenous application of the growth factor. The
tips were enlarged (average size of 2.6 xlO4 pm2) compared to control tips (5.5
xlO3 pm2) and ectopic buds (6.9 xlO3 pm2) emerged from the stalks (figure
3.12B). However, the effect of the local GDNF application on the cell
proliferation at the tips differs from that of the exogenous application of GDNF
in culture. Quantification of BrdU incorporation revealed that GDNF causes an
increase in the number of proliferating cells at the ureteric bud tips (figure
3.12C). The average number of BrdU labeled nuclei per 1000 pm of epithelium
for the control beads was 2.76 ± 0.44 and for the GDNF beads 5.69 ± 1.43 with a
p value of 0.05. This increase might be due to the gradient ofGDNF as the exact
concentration of GDNF that is released from the bead is not known.
The use of a function blocking antibody to GDNF causes reduction in ureteric
bud branching (Davies et al., 1999; Towers et al., 1998). Addition of 10 pg/ml
anti-GDNF in culture for 48 hours resulted in less branching (figure 3.13)
[(average control tip number: 7.67 ± 0.88; anti-GDNF: 1.33 ± 0.33) p= 0.01], In
addition to the reduced number of tips, their morphology was changed in the
experimental group. Since the tip could not be defined clearly by morphological
observation, the quantification of BrdU incorporation was performed on stacked
optical sections with the adjusted background threshold values, using both tip
definitions (methods IV and VIII) (figure 3.14). Both methods revealed a
significant reduction in cell proliferation at the tips when GDNF is blocked
(figure 3.15). For method IV, the average number of BrdU labeled nuclei per
1000 pm of epithelium for the tips of the control groups was 2.43 ± 0.34 and for
anti-GDNF was 1.41 ± 0.31 (p= 0.048). For method VIII, the values were 2.83 ±
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Figure 3.12: Local effect of GDNF on cell proliferation at
the tips of the ureteric bud
(A) Control beads (1% BSA) at the tips of El 1.5 kidneys in culture
for 48 hours, (B) GDNF soaked beads (50 pg/ml). Arrows showing
BrdU positive nuclei at the tips of the ureteric bud. Double staining:
TRITC-anti laminin and FITC-anti BrdU. (C) Average number of
BrdU positive nuclei per 1000 pm2 at the tips of the epithelium
(control bead: 2.76 ± 0.44, GDNF bead: 5.69 ± 1.43). Control bead
n= 23, GDNF bead n= 8 (n values represent the number of tips).
Data are shown as mean ± SEM. p= 0.05 UB: ureteric bud, MM:
metanephric mesenchyme, t: terminal tip. Scale bars = 100 pm.
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Figure 3.13: Effect of anti-GDNF antibody on cell
proliferation at the tips of the ureteric bud
(A) A control kidney cultured for 48 hours, (B) kidney culture
supplemented with 10 pg/ml function blocking antibody to GDNF for
48 hours. Arrows showing BrdU positive nuclei at the tips of the
ureteric bud. Double staining: TRITC-anti laminin and FITC-anti





Figure 3.14: Quantification methods on the effect of 10
pg/ml anti GDNF antibody on cell proliferation at the
tips of the ureteric epithelium
(A) Control. (B) 10 pg/ml anti GDNF in stack of three 3 pm
thick confocal optical sections. Panels (C-E) and (I-K) show the
same control tip, (F-H) and (L-N) show the same anti-GDNF tip
viewed in Scion Image. Panels (C, F, I, L) show the epithelium
(TRITC-anti laminin) in gray scale, (D, G, J, M) show the nuclei
(FITC-anti BrdU) in gray scale, (E, H, K, N) show the positive
BrdU nuclei for counting after adjustment of the fluorescence
intensity 3x higher the threshold of the fluorescence background






















Figure 3.15: Blocking GDNF in culture results in
reduction of cell proliferation at the tips of the
branching ureteric bud
Comparison of the two counting methods described in figure 3.14.
Data are shown as the mean of BrdU positive nuclei per 1000 pm2
of epithelial tip (control (IV): 2.43 ± 0.34, anti-GDNF (IV): 1.41 ±
0.31, control (VIII): 2.83 ±0.41, anti-GDNF (VIII): 1.59 ± 0.29).
Control n= 15, anti-GDNF n= 4 (n values represent the number of
tips). Error bars are the SEM, p= 0.048 (IV), p= 0.03 (VIII).
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These results suggest that addition of GDNF in culture does not increase the cell
proliferation at the ureteric bud tips. However, when GDNF is placed as a local
source in close proximity to the ureteric bud tips, it might stimulate cell
proliferation. Blocking GDNF in culture results in a reduction of cell
proliferation at the terminal tips of the ureteric bud branches.
3.3.6 TGF-p effect on cell proliferation at the ureteric bud tips
TGF-P has been reported to exert an inhibitory effect on branching
morphogenesis of the ureteric bud (Clark et al., 2001; Ritvos et al., 1995;
Sakurai and Nigam, 1997). Ritvos and others (1995), showed that kidneys
cultured in 1 nM TGF-P show abnormal branching with long UB branches in an
arcade fashion which branch towards the periphery of the rudiment. The aim was
to establish whether this inhibitory effect is due to regulation of cell proliferation
at the tips of the epithelium.
Kidneys were cultured for 72 hours in 1 nM TGF-P which resulted in a reduction
in branching morphogenesis (figure 3.17; control average number of tips: 15.71
± 1.02; TGF-P: 8.17 ± 0.40; p= 0.00014 <0.01). The morphology of the ureteric
buds fell into a range of phenotypes which included short branches emerging
from the stalks (figure 3.16). In order to examine whether the inhibitory effect
was due to regulation of cell proliferation at the bud tips, BrdU was incorporated
in kidneys at 24 hours in culture (figure 3.18). After just 24 hours in culture, the
TGF-p treated kidneys did not yet show a significant reduction in branching
(figure 3.17; the control average number of tips was 4.33 ± 1.20 and the TGF-P
average number was 2.67 ± 0.67 p= 0.30). However quantification of the
proliferating cells showed that at the tips of the ureteric bud cultured in 1 nM of
TGF-P, the average of proliferating cells is significantly lower (p= 1.59 xlO"5






Figure 3.16: The effect of TGF-p on ureteric bud branching
morphogenesis
(A) an El 1.5 kidney in culture for 72 hours, (B) an El 1.5 kidney in a
culture supplemented with 1 nM TGF-p. Staining: TRITC-anti laminin.



























Figure 3.17: Effect of 1 nM TGF-p on ureteric bud branching
morphogenesis in culture
El 1.5 kidneys were cultured for 24 and 72 hours in 1 nM TGF-p.
Branching is quantified as the number of terminal ureteric bud tips.
Data shown represent the average number of ureteric bud tips, error
bars are the SEM. For 24 hour culture control n= 3 , TGF-P n= 3. For









Figure 3.18: TGF-p effect on cell proliferation
(A) Control kidney in culture for 24 hours, (B) kidney in culture
supplemented with 1 nM TGF-P for 24 hours. Arrows showing the BrdU
positive nuclei on the epithelium. Double staining: FITC-anti calbindin
D28k and TRITC-anti BrdU. UB: ureteric bud, MM: metanephric
mesenchyme, t: terminal tip. Scale bars = 100 pm.
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Figure 3.19: Effect of 1 nM TGF-p on cell proliferation at
the tips of the branching ureteric bud
El 1.5 kidneys cultured in 1 nM TGF-P for 24 hours. The graph
represents the average number of BrdU positive nuclei per 1000 pm2
of the epithelium (control: 5.40 ± 0.55, TGF-p: 1.09 ± 0.48). Control
n= 13, TGF-P n= 7 (n values represent the number of tips). Data are
shown as mean ± SEM. p < 0.01
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3.4 Discussion
Localized cell proliferation is shown to be a feature of developmental shape
changes during epithelial folding and branching morphogenesis (Goldin et al.,
1984; Jernvall and Thesleff, 2000). This chapter examines whether localized
proliferation is present during branching morphogenesis of the ureteric bud. Cell
proliferation was assessed by BrdU incorporation in organ cultures for 24 hours
before fixation as previously described (Davies et al., 1995; Fisher et al., 2001;
Tokuda et al., 2003). In the experiments where the whole incubation period was
24 hours or less, BrdU was present throughout the culture period. The presence
of BrdU for the whole culture period or the last 24 hours did not seem to have
any toxic effect on the rudiments which grew and branched as normal. Other
workers, such as Tokuda and others (Tokuda et al., 2003), have also used 24
hour BrdU incubations in with no reported toxic effect.
In summary, the results show that during ureteric bud development, there is an
increase in local proliferation at the ampullary tips of the growing epithelium, a
specialization that correlates with branching activity. There is also evidence that
local proliferation is the first sign of initiation of the ureteric bud. Two known
regulators of ureteric bud branching morphogenesis (GDNF and TGF-P) were
examined in relation to their possible positive or negative effect on the localized
proliferation at the tips of the epithelium.
Localized cell proliferation at the UB tips and during UB outgrowth
During branching morphogenesis, the emergence of the new buds is an active
process which is often associated with high cell proliferation. This is the case in
the terminal endbud during branching morphogenesis of the pubertal mammary
gland (Daniel et al., 1984; Humphreys et al., 1996). In the developing salivary
gland in culture, initial cleft formation is independent of cell proliferation
(Nakanishi et al., 1987) however during branching morphogenesis labeling of
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proliferating cells with [3H]thymidine, shows specific localization on the distal
areas of the salivary epithelial lobules (Bernfield and Banerjee, 1982) less
proliferating cells in the interlobular areas and almost none in the center of the
epithelium (Bernfield et al., 1972).
The formation of new ureteric bud tips show higher localized cell proliferation
when compared to the ureteric bud stalks, a specialization of the ampullary tips
that is correlated with branching activity. When branching is arrested with
sodium chlorate, the cell proliferation at the ureteric bud tips is greatly reduced.
Previous proliferation studies in human embryonic kidneys support the current
observations that the ampullary ureteric bud tips are highly proliferative
(Nadasdy et al., 1998; Winyard et al., 1996). Other branching organs such as the
developing pancreas and lung show intense localized cell proliferation in the
areas of branching activity (Horb and Slack, 2000; Mollard and Dziadek, 1998).
In the embryonic lung, the actively growing distal bud shows a greater BrdU
labeling in comparison to interbud regions, an area that shows a relatively higher
localization of basement membrane components (Mollard and Dziadek, 1998).
Nogawa et al. showed that embryonic lung epithelia in culture show high
bromodeoxyuridine (BrdU) incorporation in areas of budding, but none in the
areas between the buds (Nogawa et al., 1998). The same study has shown that
even though lung bud formation is accompanied with differentials in localized
cell proliferation once branching morphogenesis is initiated, the initial bud
outgrowth is not triggered by induction of localized cell proliferation (Nogawa et
al., 1998). In culture (at around 8 hours), at the presumptive metanephric area
there is an increased area of localized cell proliferation where the ureteric bud
will evaginate, suggesting that localized cell proliferation might be one of the
forces that drive the ureteric bud outgrowth.
TGF-p superfamily members on cell proliferation at UB tips
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Members of the TGF-P superfamily are key regulators of metanephric
development (chapter 1). GDNF binds to GPI-anchored GDNF family receptor
al, activates the receptor tyrosine kinase Ret and signals through the MAP
kinase pathway (Saarma, 2000; Sariola and Sainio, 1997; Worby et al., 1996).
TGF-p family members signal through receptor serine/threonine protein kinases.
TGF-P binds to type II receptor (TPR-II), the complex then interacts with type I
receptor (TpR-I), type II receptor phosphorylates type I receptor, which then
phosphorylates and activates Smad proteins which carry the signal to the nucleus
(reviewed in (Massague, 1998).
The role of GDNF on the branching of the ureteric bud has already been
introduced in chapter 1. GDNF is required for ureteric bud outgrowth from the
nephric duct. It binds directly to the tips of the ureteric bud epithelium and
induces the formation of supernumerary buds (Sainio et al., 1997b). GDNF and
its receptors (GFRal, Ret) are also important for the development of enteric,
sympathetic and sensory neurons. Mutations of either the ligand or its receptors
have the same phenotype. Mice lacking GDNF, Ret or GFRal show
abnormalities in enteric nervous system and kidneys (Enomoto et al., 1998;
Moore et al., 1996; Sanchez et al., 1996). The enteric nervous system is a
complex network of interconnected neurons that regulates intestinal motility and
mucosal secretion (Costa and Brookes, 1994). The majority of the precursors of
the enteric nervous system are derived from the vagal and anterior truncal neural
crest that migrate into the developing gut (Durbec et al., 1996). In GDNF and
Ret knockout mice, no enteric neurons or glia are found below the oesophagus
and adjacent stomach (Chalazonitis et al., 1998). GDNF is a potent survival and
mitogenic factor of neural crest-derived progenitors of the enteric nervous
system (Chalazonitis et al., 1998; Heuckeroth et al., 1998; Taraviras et al., 1999;
Worley et al., 2000). GDNF is also found to be highly expressed in testis (Hu et
al., 1999). In rat, during the early postnatal period of testis development the total
number of Sertoli cells is established and is characterized by active cell
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proliferation in response to follicle-stimulating hormone (FSH) (Hu et al., 1999).
GDNF is found to stimulate the proliferation of Sertoli cells in combination with
FSH (Hu etal., 1999).
In the present study, the role of GDNF on cell proliferation at the tips of the
ureteric bud epithelium was examined. Exogenous addition of GDNF in organ
culture results in increased branching morphogenesis (Towers et al., 1998). The
hypothesis tested was whether the branch-promoting effect of GDNF is due to
stimulation of cell proliferation at the ureteric bud epithelial tips. The present
results show that when GDNF is blocked, there is a reduction in branching which
is accompanied by a reduction in cell proliferation at the tips of the branching
epithelium. However, the addition of exogenous GDNF in culture results in
enlarged ampullary tip morphology without an increase in cell proliferation. The
reason for the enlarged tip morphology observed might be due to a stimulatory
effect of the growth factor on the epithelial cell size rather than in cell numbers.
However the quantification method used in this thesis cannot determine whether
this is the case. A different approach would be to examine the effect of
exogenously added GDNF in tissue sections or on isolated ureteric bud cells in
monolayers. BrdU incorporation upon addition of GDNF would be easier to
quantify using the BrdU labeling index (percentage of BrdU positive nuclei/ 100
nuclei). Addition of GDNF to ureteric bud cells growing in certain extracellular
matrix components has been shown to be mitogenic (Towers et al., 1998).
When applied locally, GDNF might stimulate cell proliferation at the tips, but
since the exact concentration of GDNF released from the beads is not known, the
increase in cell proliferation observed might be due to high sensitivity to the
gradient. In a similar study the effect of BMP-7 soaked beads on the cell
proliferation in kidney organ cultures was examined (Piscione et al., 2001). In
that study, the effects of the ligand at specific positions relative to the bead were
determined using composite images of the explant tissue sections. The composite
images were subdivided into four concentric zones relative to the bead's
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location. The radial distance between the perimeter of each concentric zone was
75 pm. The concentration of the ligand was predicted to be the highest in the
zone area closest to the bead (zone 1) and was gradually less the further away
from the local source of BMP-7 (bead) (Piscione et al., 2001). The effect of
BMP-7 on cell proliferation at each of these 75 pm radius zones (zone 1-4) was
measured and expressed as percentage of BrdU incorporation. A similar
approach could be addressed in the case of GDNF-soaked beads and
quantification of BrdU incorporation in successive zones closer or farther to the
bead would show whether high concentration of GDNF acting locally (in close
proximity) is mitogenic. There is a potential problem with this approach,
however, because kidney cultures spread and change shape as they grow, and
measurement of the final position of a bead does not necessarily reflect where it
was as the culture was growing.
Overall the results presented here show that GDNF does not affect cell
proliferation at the tips of the actively growing ureteric bud, which is in
accordance with earlier observations (Sainio et al., 1997b). These contradict the
results of Pepicelli et al. that suggest that GDNF-regulated growth and branching
of the ureteric bud is due to the local regulation of ureter tip-specific factors and
an increase in local proliferation (Pepicelli et al., 1997). However, in the latter
study the ampullary tips of the GDNF treated kidneys appear fused (Pepicelli et
al., 1997) a finding that is validated in the present study and might be probably
due to the suggested effect of GDNF to increase cell adhesion (Sainio et al.,
1997b).
TGF-p itself as previously mentioned is a negative regulator of ureteric bud
branching. In murine kidney cultures, TGF-P 1 causes branching abnormalities;
ureteric bud branches appear elongated in an arcade fashion (Ritvos et al., 1995).
The results in this chapter show that addition of TGF-P results in a reduction of
branching after 72 hours in culture which is consistent with the findings of Clark
et al. where TGF-p 1 added to cultured rat metanephroi inhibits overall
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metanephric and ureteric bud growth, leading to reduced nephron endowment
(Clark et ah, 2001).
TGF-P can stimulate and inhibit cell proliferation in the same cell type, and is
shown to be inhibitory on proliferation of almost all non-neoplastic epithelia in
culture (reviewed in Moses et al., 1990). TGF-P inhibits cell cycle progression
by lengthening or arresting the G1 phase, through retaining the retinoblastoma
gene product (Rb) in the underphosphorylated, growth suppressive state
(reviewed in Laiho et ah, 1990; Massague, 1990).
In the current experimental system, BrdU incorporation in TGF-p treated kidneys
for 24 hours shows a significant reduction in cell proliferation at the ampullary
tips of the ureteric bud epithelium. This is similar to studies in other developing
branching organs such as the lung, mammary gland and pancreas. In the lung
organ culture, TGF-p 1 reduces branching and overall lung size (Bragg et ah,
2001; Serra et ah, 1994). TGF-P 1 treatment results in a reduction in the percent
of [ H]thymidine-labeled nuclei in the lung epithelium (Serra et ah, 1994) and
BrdU incorporation (Bragg et ah, 2001). Local administration of TGF-P in
mammary gland cultures results in inhibition on normal branching
morphogenesis. The ducts of the treated glands do not elongate and closely
resemble growth-quiescent thin-walled ducts with blunt-tipped terminal ends
(Silberstein and Daniel, 1987). The effect of TGF-P is epithelium specific at the
mammary end buds and results in a reduction ofDNA synthesis to levels similar
to the untreated growth-quiescent ducts (Daniel et ah, 1989; Silberstein and
Daniel, 1987). In the embryonic pancreas in culture, addition of TGF-P results in
a reduction in epithelial cell proliferation (at 6 days) (Sanvito et ah, 1994).
The branching phenotype obtained in the current study is not similar to the one
documented by Ritvos et ah (Ritvos et ah, 1995) where the ureteric bud branches
were elongated. The short UB branches observed are probably due to the reduced
cell proliferation at the epithelial tips. It is also possible that TGF-P may
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stimulate the deposition of extracellular matrix components or TIMP around the
developing ureteric bud tips and consequently limiting the number of branches
observed after 72 hours in culture. The action of TGF-P generally leads to up-
regulation of cell adhesion, an action mediated by enhanced synthesis and
deposition of extracellular matrix components and decreased pericellular
proteolysis (reviewed in Massague, 1990). In the developing mammary gland,
there is an elevated level of collagen type I at the end buds located near an
implanted source of TGF-P (Daniel and Robinson, 1992).
To summarize, this chapter shows that localized cell proliferation is a
specialization of the actively growing ureteric bud tips, which correlates with
branching activity as it is lost when branching is blocked. Localized cell
proliferation also appears to be the first sign of the ureteric bud as it emerges
from the Wolffian duct in culture. The experiments were performed to
investigate the pattern of cell proliferation during ureteric bud evagination and on
the branching ureteric bud epithelium in culture. In principle, it would be
possible to gain similar information in vivo by treating pregnant mice with BrdU
at different time points (i.e. El0.5 before the UB emergence from the Wolffian
duct, El 1.5, E12.0 and E12.5 before mesenchyme has started forming epithelial
structures of future nephrons (Bates et al., 2000)).
The branch-promoting effect of GDNF did not cause an increase in cell
proliferation at the tips of the ureteric bud, but instead caused expansion of the
area of bud that had tip character, whereas the branch-inhibiting effect of TGF-P
was found to be associated with less proliferation at the ureteric bud tips. GDNF
heterozygous mice have similar body weights to wild-type mice (Cullen-
McEwen et al., 2001). However GDNF heterozygous kidneys are approximately
25% smaller than the wild-type kidneys, they have abnormal shape possibly due
to defected branching morphogenesis, and they have 30% less nephrons (Cullen-
McEwen et al., 2001). It would be of interest to examine the cell proliferation
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The Cytoskeleton During Branching Morphogenesis of
the Ureteric Bud
4.1 Introduction
Morphogenetic changes occur as the result of embryonic epithelial cells
responding to signals and generating the activity that allows them to participate
in organogenesis (for review see Bard, 1992). The cytoskeleton is responsible for
much of the activity within the cell. In mammalian cells, the actin cytoskeleton
provides the driving force for cell motility and surface remodeling (Kabsch and
Vandekerckhove, 1992). The actin cytoskeleton is a highly dynamic structure
that is reshaped during the cell cycle, in response to extracellular signals and
controls cell-cell and cell-substrate interactions together with adhesion molecules
(Hall, 1994). The main mechanism by which epithelial cells change their shape
seems to be the contraction of rings of microfilaments in a purse-string
mechanism (figure 4.1).
Epithelia form contiguous sheets of cells linked by cell-cell adhesion molecules
and junctions on their lateral surfaces (for review Gumbiner, 1996). Adherens
junctions are sites of strong adhesion between the cells just below their apical
surface and are associated with actin filaments (Knust and Bossinger, 2002).
Cadherins are the major adhesion receptors of the adherens junctions, where they
colocalize with dense actin filament bundles (Gumbiner, 1996). The contractile
ring of the purse-string mechanism is composed of actin and myosin-II that
contracts resulting in wedge shaped cells (Kiehart, 1999).
During late Drosophila embryogenesis, the establishment of the dorsal ectoderm
involves a process referred to as dorsal closure (Settleman, 1999). Earlier
morphogenetic movements of the embryo leave a hole in the dorsal side of the
embryo that is covered by a thin transient epithelial structure (amnioserosa) that
ultimately degenerates (Settleman, 1999). Dorsal closure involves the movement
of the lateral epidermal epithelial sheets from each side of the embryo that zip
together at the dorsal midline to form one contiguous epithelial sheet (Grose and
Martin, 1999; Settleman, 1999). This process involves cytoskeleton-mediated
cell shape changes, by formation of an intracellular actin-purse string (Harden et
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(From Nodder and Martin, 1997)
Figure 4.1: Purse-string mechanism
Intracellular actin filaments anchor into adherens junctions at
the apices of epithelial cells. Contraction of the actin cables
results in a change of the cell shape into wedges and a
subsequent movement of the epithelial sheet.
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ai, 1999). Actin filaments and myosin are accumulated at the leading edge of the
lateral epithelial cells and contraction leads to the epithelial sheets meeting and
fusing at the dorsal midline (Grose and Martin, 1999). The process is mediated
by members of the Rho family of small guanosine triphosphatases (GTPases)
that are key regulators of the actin cytoskeleton (Harden et al., 1999; Settleman,
2000).
Partial purse-string mechanism is common in invaginations of the epithelial
sheets during morphogenesis (Kiehart, 1999). An example of this can be found in
the morphogenetic changes during fold formation of the proximal rat colon
(Colony and Conforti, 1993). During fold formation, actin microfilaments are
observed in cells located at the apices of the developing folds (figure 4.2).
During branching morphogenesis in the developing salivary gland, the actin
cytoskeleton is important for the epithelial cell shape changes (Hardman and
Spooner, 1992b; Spooner, 1973). Actin microfilament contraction in the apices
of the epithelial cells of the developing salivary gland is associated with tip
formation. Disruption of the cytoskeleton results in loss of clefts and arrest of
branching morphogenesis (Spooner, 1973).
Aim
The aim of this chapter is to find (i) whether the cytoskeleton has a special
arrangement in the ureteric bud, which correlates with the branching activity and
(ii) whether the cytoskeletal elements of the ureteric epithelium play an
important role in branching morphogenesis.
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(From Colony and Conforti, 1993)
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(From Grose and Martin, 1999)
Figure 4.2: Epithelial cell movement during development
(A) Actin filament localization in the apices of the folds of E,20
proximal colon (arrow) (B) Dorsal closure in the late Drosophila
embryo where a contractile actin cable in the leading edge cells
draws the epidermis over the exposed amnioserosa.
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4.2 Results
4.2.1 Localization of actin filaments at the ureteric bud tips during
branching morphogenesis
In order to test whether the cytoskeleton shows special arrangement during the
shape changes occurring during ureteric bud branching, the first step was to
characterize the expression pattern of actin in the developing collecting duct. The
localization of actin filaments was assessed using the mushroom toxin phalloidin
which is extensively used to visualize actin filaments within cells (VanBuren et
al., 1998; Wulf et al., 1979). Phalloidin binds to actin filaments, enhances
polymerization of actin and stabilizes actin filaments (Cooper, 1987; Sampath
and Pollard, 1991).
Isolated El 1.5 kidney rudiments were cultured in standard medium for a time
course of 24 to 72 hours and were stained using rhodamine conjugated
phalloidin. As shown in figure 4.3, there was a strong phalloidin staining of the
actin filaments concentrated on the ureteric bud epithelium in comparison to the
mesenchyme which does not stain as much. The expression of actin filaments on
the epithelium is concentrated at the apical ends of the ureteric bud tips
throughout the culture period (figure 4.3).
To test whether the very strong expression of filamentous actin at the tips of the
branching epithelium correlates with branching activity, branching was arrested
using either sodium chlorate or a MAP kinase inhibitor (PD98059). El 1.5 kidney
rudiments were cultured for 24 hours in standard medium (control) or in the
presence of 30 mM sodium chlorate which blocks branching morphogenesis of
the ureteric bud as previously mentioned (Davies et al., 1995). Rhodamine
conjugated phalloidin staining in chlorate-treated kidneys shows a different actin
filament distribution than in control kidneys. When ureteric bud branching is
blocked, filamentous actin is uniformly distributed on the ureteric bud epithelium
with loss of the specific localization of F-actin from the tips of the ureteric buds
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Figure 4.3: Localization of actin filaments at the tip ends of the
branching ureteric bud in culture
(A) El 1.5 kidney in culture for 24 hours, (B) 48 hours and (C) 72 hours.
Kidneys are stained with TRITC-phalloidin which stabilizes the
microfilaments. Filamentous actin is strongly expressed at the apical parts
of the ureteric bud tips. Arrows show the localization of actin filaments at
the epithelial tips. UB: ureteric bud, MM: metanephric mesenchyme, F-:
filamentous. Scale bars =100 pm.
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(figure 4.4). This result suggests that the special arrangement of F-actin at the
tips of the ureteric bud is present during branching activity and is lost when
branching is blocked.
Kidneys were also cultured for 48 hours in the presence of 10 pM PD98059, a
MAP kinase inhibitor that blocks the branching but not extension of the ureteric
bud resulting in less but longer branches (Fisher et al., 2001). Again, when
branching is blocked, phalloidin staining differs from that in the controls (figure
4.5). The fluorescence is found higher at the ureteric bud tips but actin cables
appear disrupted when compared to actin filaments in control tips.
The above results show that during branching activity there is a specialized
arrangement of actin filaments at the apical areas of the ureteric bud tips. This
specialization occurs during branching and is lost when branching is arrested.
4.2.2 Localization of actin filaments during ureteric bud outgrowth
from the Wolffian duct
Ureteric bud appears as a "tip'Mike outgrowth from the Wolffian duct. To test
whether the shape changes, during the evagination process, are accompanied by
changes in the cytoskeleton, Wolffian ducts and surrounding mesenchyme were
isolated from El0.5 embryos before ureteric bud outgrowth. The Wolffian ducts
and surrounding mesenchyme were cultured for 12 hours. In culture, by this time
the ureteric bud has emerged from the duct but has not yet branched. Rhodamine
conjugated phalloidin staining showed high expression of actin filaments at the
apical part of the newly formed ureteric bud (figure 4.6).
This result suggests that the first ureteric bud branch from the Wolffian duct is
like the ureteric bud branches inside the developing metanephros and that












1 -actin < '
"a
Figure 4.4: Localization of actin filaments in chlorate-treated
kidneys where normal branching is disrupted
(A) An El 1.5 metanephros in control culture for 24 hours showing
normal branching and filamentous actin distribution at the apices of the
ureteric bud tip cells (arrows), (B) an El 1.5 metanephros in culture
supplemented with 30 mM sodium chlorate showing disrupted
branching morphogenesis. F-actin (arrows) on the chlorate-treated
epithelium appears similar to the microfilament distribution in the
control UB stalks. Staining: TRITC-phalloidin. UB: ureteric bud, MM:
metanephric mesenchyme, F-: filamentous. Scale bars =100 pm.
Figure 4.5: Localization of actin filaments in kidneys
where branching is arrested through MAP kinase
inhibition
(A) F-actin localization at the tips of the epithelium in a control
kidney cultured for 48 hours, (B) F-actin distribution is altered on
the epithelium of a kidney cultured for 48 hours at 10 pM PD98059.
Arrows show the actin filaments. Staining: TRITC-phalloidin. UB:
ureteric bud, MM: metanephric mesenchyme, F-: filamentous. Scale
bars =100 pm.
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Figure 4.6: Actin localization during ureteric bud outgrowth
from the Wolffian duct in culture
An El0.5 Wolffian duct in culture for 12 hours. White arrow shows the
emerging ureteric bud at the caudal end of the duct, yellow arrow shows
the filamentous actin localized at the outgrowing tip of the bud.
Staining: TRITC-phalloidin. WD: Wolffian duct, UB: ureteric bud, F-:
filamentous. Scale bar =100 pm.
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4.2.3 Inhibition of actin on ureteric bud branching morphogenesis
Rhodamine conjugated phalloidin staining has shown a special arrangement of
actin filaments at the tip ends of the ureteric bud epithelium during branching,
which is lost when branching is blocked. In order to examine whether this special
arrangement of F-actin is important for branching, the effect of disrupting actin
filaments on branching morphogenesis was investigated.
Cytochalasin D is a mold metabolite, which binds with high affinity to the
barbed end of actin filaments (Cooper, 1987). It inhibits actin polymerization and
disrupts actin organization (Cooper, 1987; Soong et al., 1990). Cytochalasin D is
used in various studies that investigate the effect of actin disruption in epithelial
shape changes (Colony and Conforti, 1993; Soong et al., 1990). The latter study
shows that cytochalasin D at concentrations ranging from 1.0 pg/ml to 0.1 pg/ml
has an inhibitory effect on corneal epithelial cell migration, with complete
migration arrest at 0.5 pg/ml (Soong et al., 1990). Therefore, I decided to start at
this concentration in the present organ culture system.
Kidney rudiments were initially cultured for 72 hours at 0.5 pg/ml cytochalasin
D. At this concentration, branching and growth of the epithelium was completely
inhibited (figure 4.7). At lower concentrations (0.3 and 0.1 pg/ml), the effect was
inhibitory and the morphology of the epithelium was distorted (figure 4.8). At
0.3 p.g/ml cytochalasin D, the ureteric bud stalk branches appeared swollen, with
minimal ramification at the terminal branches reflecting the importance of the
intact cytoskeleton in ureteric bud tissue integrity. At the lowest concentration
(0.1 pg/ml) which is a very low concentration, the morphology of the ureteric
epithelium appeared swollen to a lesser extend than at 0.3 pg/ml without
blocking branching morphogenesis (figure 4.8). The stalk branches appeared
swollen and the ureteric bud tips were funnel-shaped. The effect of cytochalasin
D was tested for reversibility at the lowest concentration 0.1 pg/ml. Kidneys
were cultured for 24 hours at 0.1 p.g/ml cytochalasin D and then they were
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Figure 4.7: The effect of blocking actin polymerization on
branching morphogenesis
(A) kidney cultured in 0.5% DMSO as control for 72 hours, (B)
kidney cutlured in 0.5 (j.g/ml cytochalasin D. Staining: FITC-anti
calbindin D28k. Scale bar =100 fun.
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Figure 4.8: Effect of lower concentrations of cytochalasin D on
branching morphogenesis in culture
Kidney rudiments were cultured for 72 hours in (A) 0.03% DMSO
(control), (B) 0.3 pg/ml cytochalasin D (a double ureter is present), (C)
0.001% DMSO (control) and (D) 0.1 pg/ml cytochalasin D. In (B) and (D)
the background fluorescence has been removed (using Adobe photoshop)
for aesthetic purposes only and the originals have been included as small
inserts at the bottom left of each picture. Staining: TRITC-anti calbindin
D28k. Scale bars = 100 pm.
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transferred to control culture medium for further 24 hours. Branching
morphogenesis was resumed in control culture medium (figure 4.9).
The effect that 0.1 pg/ml cytochalasin D has on ureteric bud branching was
investigated in a time course of 24, 48 and 72 hours (figure 4.10). At 24 hours,
the ureteric bud tips showed an enlarged morphology (figure 4.10 A-F) in
relation to the control tips. As branching morphogenesis progressed, this
expanded tip morphology persisted at both culture times of 48 and 72 hours in
relation to control tips (figure 4.10 G-L and M-R). The branching (that is, the
number of ureteric bud tips) was reduced at all time points in relation to controls
(figure 4.11). At 24 hours the average number of control tips was 6.3 ± 0.25 and
the cytochalasin D treated kidney tips were 3.3 ± 0.63 (p= 0.012; < 0.05). At 48
hours, the average number of the control tips were 14.5 ± 1.89 whereas the
cytochalasin D treated tips were 8 ± 1.05, (p= 0.03; <0.05). By 72 hours in
culture, the average number of tips was 17.5 ± 2.40 for the control kidneys and
11 ± 1 (p= 0.067) for the kidneys cultured in 0.1 pg/ml cytochalasin D. The
expanded morphology of the ureteric bud tips when kidneys were cultured for 48
and 72 hours in 0.1 pg/ml cytochalasin D was accompanied by scattering of
some epithelial cells into the surrounding mesenchyme (figure 4.12).
Whether the scattering of the epithelial tip cells observed in kidneys cultured in
cytochalasin D was a feature of the branching activity was investigated. Kidneys
were cultured for 72 hours in 30 mM of sodium chlorate to block branching
activity. Cytochalasin D (at 0.1 pg/ml) was added during the whole culture
period to test whether the tip cells would scatter. The morphology of the ureteric
bud was chlorate-like and there was no cell scattering observed at the tips of the
branching arrested epithelium (figure 4.13). This suggests that the cells of the
actively growing tips are probably in a less stable state in comparison to the cells
of the ureteric bud stalks. This less stable state allows cells at the tips to scatter
when actin cytoskeleton is mildly disrupted with 0.1 pg/ml Cyto D. When the
tips are not active (as in chlorate treated kidneys) the cells are probably more
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Figure 4.9: The effect of 0.1 pg/ml cytochalasin D on
branching morphogenesis of the ureteric bud is reversible
(A) control El 1.5 kidney after 24 hours in culture, (B) kidney cultured for
24 hours in the presence of 0.1 pg/ml cytochalasin D, (C) kidney cultured
for 24 hours in 0.1 pg/ml cytochalasin D and transferred for further 24
hours in control culture medium. Branching morphogenesis was
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Figure 4.11: Low concentration of cytochalasin D (0.1 pg/ml)
results in a decrease in ureteric bud branching in culture
El 1.5 kidney rudiments were cultured for 24-72 hours in culture medium
(control) or supplemented with 0.1 pg/ml cytochalasin D. Branching is
quantified as the number of terminal ureteric bud tips under each
treatment. Data shown represent the average number of ureteric bud tips,
error bars are the SEM.
Control (24h) n= 4, Cyto D (24h) n= 4
Control (48h) n= 4, Cyto D (48h) n= 5
Control (72h) n= 4, Cyto D (72h) n= 3
(n values represent the number of kidneys)
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Figure 4.12: Low concentration of cytochalasin D causes cell
scattering at the tips of the ureteric bud
(A-C) high magnification of a confocal image of a ureteric bud terminal
tip after 72 hours in a control culture, (B) shows the localization of actin
filaments at the tips, (C) shows the epithelium. (D-F) high magnification
of a tip after 72 hours in a culture supplemented with 0.1 pg/ml
cytochalasin D, (E) shows the disruption of the actin filaments at the tip
ends, (F) shows the epithelial cells scattering (yellow arrows). Double
staining: TRITC-phalloidin in (B) and (E), FITC- anti calbindin D28k in
(C) and (F). Panels (A) and (D) are merged confocal images. Scale bars =
100 pm.
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Figure 4.13: The ceil scattering effect of cytochalasin D at the
ureteric bud tips, occurs during branching morphogenesis
(A) a kidney in a control culture, (B) a kidney in a culture supplemented with
30 mM sodium chlorate, (C) a kidney in a culture supplemented with 0.1
pg/ml cytochalasin D, (D) a kidney in a culture supplemented with 30 mM
sodium chlorate and 0.1 pg/ml cytochalasin D. All cultures were for 72
hours. In (C) the arrows show the scattering of the cells at the tip ends of the
ureteric bud. Staining: FITC-anti calbindin D28k. UB: ureteric bud, MM:
metanephric mesenchyme, t: terminal tip. Scale bar = 100 pm.
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stable and mild disruption of the actin cytoskeleton does not result in scattering.
Therefore, inhibiting actin filament formation at the very low concentration
affects the stability of the cells at the ureteric bud tip ends, rather than the whole
of the ureteric bud.
These results show that at very low concentrations, inhibition of actin filament
polymerization sustains the branching of the ureteric bud epithelium and results
in expanded tip morphology. The scattering of some of the epithelial cells from
the tip ends which occur only when branching morphogenesis is taking place and
not when branching is blocked, also suggests that during branching the cell
junctions at the ureteric bud tips may be less stable and that the mild disruption
of the actin cytoskeleton causes them to scatter.
4.2.4 Adherens junctions at the ureteric bud tips
Cell adhesion is crucial for the assembly, the structural integrity and the
organization of epithelia into three-dimensional tissues of animals (Gumbiner,
1996). Adherens junctions are regions of the plasma membrane where E-
cadherin molecules function as cell adhesion molecules and actin-based
cytoskeleton is assembled where adjacent epithelial cells contact each other
(Nagafuchi, 2001).
The scattering cells at the tips of the ureteric bud, when actin cytoskeleton is
mildly disrupted, support the hypothesis that the cell-cell junctions at the tip ends
may be less stable. In order to investigate this hypothesis, kidneys were cultured
for 24 hours at 0.1 pg/ml cytochalasin D. They were then immunostained with
anti E-cadherin antibody and the distribution of E-cadherin was compared to
control tips. The results showed that there is a difference in the expression
pattern ofE-cadherin at the tips of the branching epithelium when actin filaments
are disrupted (figure 4.14). The control kidneys show E-cadherin staining
expressed at the apical parts of the tips in a similar localization pattern as seen
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for actin filaments. In the kidneys treated with cytochalasin D, the cells of the
ureteric bud appear to have lost their epithelial polarity. E-cadherin expression
shows that it is not localized only at the apices of the tip cells but also to the
basal surfaces. The cell layer at the tip edge (figure 4.14E) also shows weaker E-
cadherin staining than the rest of the cyto D treated epithelial tip.
4.2.5 Role of myosin during ureteric bud branching morphogenesis
Filamentous actin and associated myosins take part in cellular processes like cell
motility and contraction. A contractile actin-myosin purse-string mechanism may
be involved during ureteric bud branching morphogenesis. In order to investigate
this hypothesis, the acto-myosin contractility on ureteric bud branching
morphogenesis was examined by inhibition of myosin.
Butanedione monoxime (BDM) is a general myosin ATPase inhibitor that acts
directly on myosin molecules, inhibits actin-myosin interaction in vitro and is
widely used as a non-muscle myosin inhibitor (Cramer and Mitchison, 1995;
Herrmann et al., 1992; Soeno et al., 1999; Steinberg and Mcintosh, 1998).
Subsequently, pharmacological inhibition of myosin with BDM was used in the
current organ culture system. El 1.5 kidneys were cultured for 72 hours in the
presence of 20 mM BDM. At this concentration, the effect was clearly inhibitory
on branching and probably lethal (figure 4.15). Kidneys were then cultured at
lower concentrations of BDM (10 mM and 5 mM) for 72 hours (figure 4.16).
The effect of myosin inhibition on ureteric bud branching was inhibitory and
dose dependent (figure 4.17). Inhibiting myosin resulted in less branching. The
average number of ureteric bud tips at 10 mM was 15.2 ±2.3, at 5 mM it was
23.3 ± 2.5 in comparison to the controls which was 34.5 ± 2.9. The morphology
of the branching epithelium from the BDM treated kidneys appeared similar to
the controls. The inhibitory effect of BDM was reversible. To demonstrate this,






Figure 4.15: The effect of myosin inhibition on branching
morphogenesis
(A) El 1.5 kidney in culture for 72 hours, (B) kidney in culture
supplemented with 20 mM BDM. Staining: FITC-anti calbindin D28k.
UB: ureteric bud, MM: metanephric mesenchyme.
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Figure 4.16: The inhibition of myosin reduces branching
morphogenesis of the ureteric bud
(A) Control kidney in culture for 72 hours, (B) supplemented with 5
mM BDM, (C) 10 mM BDM. Staining: FITC-anti calbindin D28k. UB:
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Figure 4.17: Myosin inhibition results in a decrease in
branching morphogenesis
El 1.5 kidney rudiments were cultured for 72 hours in culture medium
(control) or supplemented with 5 mM, 10 mM BDM. Branching is
quantified as the number of terminal ureteric bud tips under each
treatment: control: 34.5 ± 2.9, BDM (5 mM) : 23.3 ± 2.5, BDM (10
mM): 15.2 ± 2.3. P= 0.007 <0.01 between control and BDM (5mM), p=
2.59 xlO"5 < 0.01 between control and BDM (10 mM). Control n= 16,
BDM (5 mM) n= 11, BDM (10 mM) n= 11 (n values represent the
number of kidneys). Data shown represent the average number of
ureteric bud tips, error bars are the SEM.
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culture medium for further 24 hours and 48 hours. By that period the branching
was recovered (figure 4.18).
These results suggest that actin-myosin contractility is important for efficient
ureteric bud branching morphogenesis.
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Figure 4.18: The effect of 5 mM BDM on ureteric bud
branching morphogenesis is reversible
(A) Control kidney culture for 24 hours, (B) culture supplemented with
5 mM BDM for 24 hours, (C) a kidney cultured for 24 hours at 5 mM
BDM and further 24 hours under control conditions, (D) a kidney
cultured for 24 hours at 5 mM BDM and 48 hours under control
conditions. Staining: FITC-anti calbindin D28k. UB: ureteric bud, MM:
metanephric mesenchyme. Scale bar =100 pm.
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4.3 Discussion
The rearrangement of the cytoskeleton is responsible for the epithelial shape
changes that occur during embryonic development. Healing of wounds in single
cells or embryonic tissues requires actomyosin contraction (Bement et al., 1999;
Grose and Martin, 1999; Kiehart, 1999). During single-cell wound healing in
Xenopus oocytes, actin filaments and myosin are recruited independently to the
wound borders (Bement et al., 1999). Their purse string contraction results in
wound edges constriction, a process dependent on a Rho GTPase (Bement et al.,
1999). Small skin wounds in embryos heal by contraction of an actin cable that is
assembled on the front row of epidermal cells (Martin and Lewis, 1992). At the
wound margins, myosin II is localized at the sites of the actin cables, as well as
cadherins are clustered where actin cables are linked in adjacent cells via
adherens junctions (Brock et al., 1996). The cells at the wound margins become
wedge shaped, via the contractile force which pulls the wound edges together
(Brock et al., 1996; Nodder and Martin, 1997).
The formation of tubes and branching structures during organogenesis is
accompanied with a great deal of shape change that involves rearrangement of
the cytoskeleton. During ureteric bud branching morphogenesis in culture,
phalloidin staining shows a strong localization of the actin filaments at the apical
areas in the tips of the epithelium. This special localization of actin filaments is
present when the ureteric bud evaginates as a single tip from the Wolffian duct
and persists at the newly formed tips throughout the culture period examined
(24-72 hours). This special arrangement of the microfilaments in the UB tips is
present during branching activity and disappears when branching is arrested
either in chlorate-treated kidneys or when branching is blocked with the MAPK
inhibitor PD98059. In the latter treatment, phalloidin staining reveals focal
aggregates of actin present in the ureteric bud tips and at the stalks. In the
developing lung in culture, at the postbudding stage (48 hours), when the buds
have elongated, actin filaments show a strong localization at the tips of the
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branches in comparison to the clefts, a specialization associated with branching
activity (Miura and Shiota, 2000). However, in contrast with the high actin
localization at the apical part of the evaginating ureteric bud (24 hours in
culture), no specific localization of actin is present at the prebudding stage of the
developing lung (6 hours in culture) when no clefts are present yet (Miura and
Shiota, 2000). Also, there is no specific actin arrangement in the clefts or the bud
tips at the onset-budding stage (24 hours in culture), when clefts have started to
form (Miura and Shiota, 2000).
Cytochalasin D is a specific actin filament depolymerization agent that does not
appear to disrupt other cell functions significantly (Colony and Conforti, 1993;
Cooper, 1987). It is widely used in studies to reversibly disrupt the actin
cytoskeleton (Bement et al., 1999; Colony and Conforti, 1993; McCluskey and
Martin, 1995; Soong et al., 1990; Stevenson and Begg, 1994). In embryonic
epidermal wound healing, addition of Cyto D blocks formation of the actin cable
at the wound margins and leads to failure of reepithelialisation (McCluskey and
Martin, 1995). In single-cell wounds in Xenopus oocytes, cytochalasin D also
prevents wound closure (Bement et al., 1999).
In the developing ureteric bud, addition of cytochalasin D results in an arrest of
branching morphogenesis at concentration 0.5 pg/ml and a disruption of ureteric
bud branching morphology at lower concentrations 0.3 and 0.1 pg/ml. The effect
of 0.1 pg/ml cytochalasin D, a very low concentration, is reversible and does not
affect branching activity which takes place as revealed in the time course of 24 to
72 hours. At this concentration of the actin disrupting agent, the UB tips show an
enlarged morphology with funnel-shaped ampullary ends. Some cells at the
enlarged tips scatter in comparison to the stalk cells and reflect a probable less
stable state of cell-cell contacts at the newly formed tips (sites of branching
activity). This is not observed when branching activity is arrested in chlorate-
treated kidneys. The cells at the stalks of the ureteric bud, cultured in very low
concentration of cytochalasin D, do not show any signs of scattering reflecting
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that, as branching progresses, the cells at the stalks establish mature cell-cell
contacts that are not subject to mild disruption of the actin cytoskeleton. The cell
scattering at the newly formed tips observed after mild disruption of the actin
filaments suggest that the cell-cell contacts might not be stable yet.
The majority of F-actin in epithelial cells localizes in adhesive belts that
encircles the cell just below the apical surface at the adherens junctions
(Gumbiner, 1996; Knust and Bossinger, 2002). The transmembrane core of
2+adherens junctions consists of cadherins that are transmembrane Ca -dependent
homotypic adhesion receptors (Gumbiner, 1996; Vasioukhin and Fuchs, 2001).
During embryonic wound healing, E-cadherin molecules are associated with
actin filament cable at the leading edge (Danjo and Gipson, 1998). Disruption of
E-cadherin caused disruption of the actin filaments at the wound margins and
subsequent torn uneven epithelial wound margin (Danjo and Gipson, 1998).
Immunostaining of E-cadherin in the developing ureteric bud shows localization
at the apical parts of the UB tip cells in a similar expression to actin filaments, as
seen with phalloidin staining. Disruption of actin filaments with the lowest
cytochalasin D concentration (0.1 pg/ml) alters E-cadherin distribution
throughout the ureteric bud epithelium, with weaker staining at the cell-cell
contacts in the cell layer at the edge of the tips. In primary keratinocytes,
addition of cytochalasin D also results in disruption of the adhesion contacts
between cells, even though some cadherin is still localized to cell borders
(Vasioukhin et al., 2000). In MDCK epithelia cells, new cell-cell contacts are not
formed upon addition of cytochalasin D; the young contacts disassemble whereas
the more mature cell-cell contacts are not disrupted (Adams et al., 1998).
Rho family of small GTPases are known regulators of the actin cytoskeleton
(Ridley, 1999; Settleman, 2000; Van Aelst and D'Souza-Schorey, 1997) and
mediate cell signaling responses to direct rearrangement of the actin cytoskeleton
during development (Settleman, 1999). In epithelial cells, members of the Rho
GTPases such as Rho and Rac are required for the establishment of cadherin
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mediated cell-cell adhesion and the actin cytoskeleton (Braga et al., 1997; Evers
et al., 2000). Blocking the function of endogenous Rho and Rac prevents the
establishment of cadherin-mediated cell-cell contacts and blocking Rac function
prevents actin recruitment to cadherin complex in keratinocytes (Braga et al.,
1997). In the Drosophila tracheal system, dominant negative Rac results in an
increase in E-cadherin levels, loss of distinction between the apical-basolateral
domains in cell contact, in addition with expanded F-actin distribution, and an
increase of the amount of cytoplasmic actin (Chihara et al., 2003).
Hyperactivation of Rac, in the same system, disrupts the cell adhesion in the
epithelium resulting in detachment of cells from the tracheal cell cluster (Chihara
et al., 2003). In the Rac mutant embryos, the tracheal terminal branches are lost
(Chihara et al., 2003). It would be of interest to examine the role of the Rho
family of small GTPases at the cytoskeletal organization and cell-cell contacts at
the tips of the developing ureteric epithelium.
Myosin II co-localizes along the actin filaments in wound margin during wound
healing and its inhibition results in inhibiting wound closure (Bement et al.,
1999; Danjo and Gipson, 1998). I was unable to identify the precise localization
of myosin on the ureteric bud epithelium by immunohistochemistry in whole
mounts due to the presence of both UB and mesenchymal components. Myosin
was reversibly inhibited using butanedione monoxime (BDM), a general myosin
ATPase inhibitor, which resulted in reduced branching morphogenesis in a dose
dependent manner. At 20 mM, the effect of BDM on the ureteric bud epithelium
was probably lethal as no morphogenesis took place in accordance with a
previous study in fission yeast where at concentrations above 15 mM the effect
of the drug was lethal (Steinberg and Mcintosh, 1998). BDM (10 mM) reversibly
inhibits postmitotic epithelial cell spreading without directly disrupting actin
filaments at this concentration (Cramer and Mitchison, 1995). In Xenopus
oocytes, wound healing actin is accumulated at the wound closure margins in the
presence of much higher BDM concentrations suggesting that actin is not
directly affected from the drug (Bement et al., 1999; Kiehart, 1999).
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The experiments described above, were performed using the metanephric organ
culture that allows the manipulation of organotypic branching morphogenesis.
Pharmacological disruption of the cytoskeletal elements in this experimental
model system allows direct visualization of the effects on the branching
architecture. However, the drawback of the results in this chapter is the presence
of both epithelial and mesenchymal compartments and the experimental
disruption of the actin or myosin might be affecting the mesenchyme. Hence, the
effects of cytochalasin D or BDM on the epithelial branching morphogenesis
observed might also be due to their indirect effects on the mesenchymal cells.
The isolated ureteric bud three-dimensional tubulogenesis model, recently
developed after the above experiments were complete, would be a more
appropriate system to study the questions addressed here as it displays an
organotypic ureteric bud branching morphogenesis without the presence of the
mesenchyme (Sakurai et al., 2001).
To summarize, this chapter focuses on the cytoskeletal elements involved during
branching morphogenesis of the ureteric epithelium. It shows that branching
morphogenesis is dependent on actin-myosin contractility. Blocking either actin
microfilament formation or myosin results in a disrupted epithelial morphology
or a reduction of branching, respectively. Actin filaments show a strong
expression at the tips of the branching ureteric buds, a special arrangement
correlated with branching activity. Mild disruption of the actin cytoskeleton
results in expanded tip morphology and altered cell junctions.
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Chapter 5
Specializations at the Tip of the Branching Ureteric Bud




Plant lectin binding studies have offered information regarding the presence and
compartmentalization of sugar residues in tissues. They have been used to reveal
tissue-bound glycocongugates during limb development, or development of
organs including the pancreas and kidney (Laitinen et al., 1987; Maylie-
Pfenninger and Jamieson, 1980; Milaire, 1991). Dolichos Biflorus Agglutinin
(DBA) is a plant lectin which recognizes a-linked A-acetylgalactosamine and
has been extensively used as a tissue marker for the collecting duct epithelia
(Qiao et al., 2001; Qiao et al., 1999b).
The evidence for the DBA reacting with collecting ducts in adult kidneys of
many species including mouse, rat, rabbit and human comes from a comparative
study of 14 species (Holthofer, 1983). In adult rat kidney collecting ducts, DBA
binds to the apical cell membranes of the principal cells along the entire length of
the collecting duct (Brown et al., 1985). It also stains the intercalated cells
(Murata et al., 1983) in a heterogeneous pattern so that DBA binds strongly to
their apical plasma membranes from the cortex and outer stripe of the outer
medulla (Brown et al., 1985). In adult mouse kidneys, DBA shows strong
reactivity with the intercalated cells of the collecting duct (Laitinen et al., 1987).
In embryonic rat kidneys (Er 18), DBA shows binding to most cells of the
collecting duct (Holthofer, 1988). In embryonic mouse kidneys, DBA shows
specific reactivity with the developing collecting ducts from at least as early as
embryonic day 13 (Laitinen et al., 1987). At around El5, cells with the
respective morphology of principal and intercalated cells evolve in the deep
cortical part, and here there is a heterogeneous DBA staining on the epithelial
cells as early as E13 (Laitinen et al., 1987).
In the present study, I show that DBA binding shows a specialized expression
pattern at the developing ureteric bud epithelium at an even earlier stage, and this
pattern again emphasizes that the tip cells differ from those of the stalks.
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5.2 Results
5.2.1 Lack of DBA binding to the ureteric bud tips during branching
morphogenesis
Kidney rudiments were cultured for 24, 48 and 72 hours and stained with
fluorescein labeled Dolichos Biflorus agglutinin. At each of these time-points,
they showed a distinct expression pattern: the binding of the lectin was absent
from the tips of the ureteric bud although the stalks stained strongly (figure 5.1).
DBA binding in the stalks appears to stain the basement membrane as the lectin
staining is similar to the anti-laminin staining.
5.2.2 Changes in DBA binding at the ureteric bud tips when
branching is regulated
In order to examine whether the absence of DBA staining at the tips of the
ureteric bud is a special feature of the actively growing epithelium, the effects of
exogenous GDNF or a function-blocking antibody to GDNF on DBA staining
were studied.
As described in chapter 3, the addition of exogenous GDNF increases the
ureteric bud terminal tip area and induces the appearance of ectopic tips from the
ureteric bud stalk. Therefore 100 ng/ml of recombinant GDNF were added to the
cultures for 48 hours and ureteric buds were double stained with TRITC anti-
laminin and FITC-DBA. The GDNF-enlarged ureteric bud tips lacked DBA
binding (figure 5.2). The ectopic buds emerging from the stalk also showed lack
of binding to the lectin (figure 5.2 J-L), but the stalks themselves still bound
lectin strongly.
Blocking GDNF signaling in culture results in a reduction of branching
morphogenesis. Kidneys were cultured at 10 p.g/ml anti GDNF function blocking
antibody for 48 hours. Under these conditions binding ofDBA was found
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Figure 5.1: Dolichos Biflorus agglutinin binding on the ureteric
bud epithelium during branching morphogenesis in culture
Kidney rudiments in culture for 24 hours shown in (A-C), 48 hours in (D-F)
and 72 hours in (G-I) double stained for FITC-Dolichos Biflorus Agglutinin
(B, E, H) and TRITC- anti laminin (C, F, I). Arrows show the exclusion of
the DBA from the tips of the ureteric epithelium. Panels (A, D, G) show the
merged confocal pictures. UB: ureteric bud, MM: metanephric mesenchyme,





Figure 5.2: The effect of exogenous GDNF on Dolichos Biflorus
agglutinin binding at the terminal tips of the ureteric epithelium
(A-C) a kidney cultured under control conditions for 48 hours, (D-L) a
kidney cultured in medium supplemented with 100 ng/ml GDNF for 48
hours. Panels (G-I) show a higher magnification of confocal picture (D), the
arrows show the enlarged ureteric bud tips after exogenous GDNF
administration in culture. In panels (J-L) the open arrows show the presence
of ectopic tips along the stalk of the epithelium. Double staining: FITC-DBA
(B, E, H, K) and TRITC-anti laminin (C, F, I, L), panels (A, D, G, J) are
merged confocal pictures. UB: ureteric bud, MM: metanephric mesenchyme,
t: terminal tip. Scale bars = 100 pm.
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throughout the epithelium including the tips (figure 5.3). These results suggest
that absence of DBA staining correlates with branching activity, and DBA-
negativity might be a marker of active ureteric bud tips.
5.2.3 The transition between tip and stalk is reversible
The ureteric bud evaginates from the Wolffian duct as a tip-like outgrowth which
then elongates and divides dichotomously, initially to form a T-shape structure
with two tips 180° apart. During branching, the first two tips become stalks as
their tips continue to grow and bifurcate. In the normal course of events,
therefore, tips give rise to stalk cells.
In culture, newly formed tips show a characteristic lack of DBA binding as do
ectopic buds emerging from the ureteric bud stalks where tips are not normally
formed (see above). To test whether stalks that are DBA-positive are able to
form tips which lack DBA binding, we developed a method to induce new tip
formation from established stalks. El 1.5 isolated kidneys were further
microdissected as shown in figure 2.3 (chapter 2). One tip was removed
mechanically from the T-shape stage ureteric buds and extra metanephric
mesenchyme was placed next to the resulting T-shape ureteric buds. The control
kidneys were cultured for 24 hours whereas the amputated T-shape ureteric buds
were cultured for 48 hours to achieve equal branching. Lectin histochemistry



















Figure 5.3: The effect of a function blocking antibody to GDNF
on Dolichos Biflorus agglutinin binding at the terminal tips of
the ureteric epithelium
(A-C) a control El 1.5 kidney in culture for 48 hours, (D-F) a kidney in
culture supplemented with 10 pg/ml function blocking anti-GDNF for 48
hours. (B) shows DBA binding missing from terminal tips in control
organ, (E) shows DBA binding throughout the epithelium in experimental
rudiment, arrows show the terminal tips. Double staining: FITC-DBA (B,
E) and TRITC-anti laminin (C, F). Merged confocal images (A, D). UB:



















Figure 5.4: Dolichos Biflorus agglutinin binding at the newly
formed tips of the ureteric epithelium
(A-C) a control kidney in culture for 24 hours, (D-F) a T-shaped ureteric
bud in culture for 48 hours which has formed new branches (yellow
arrows). (B) and (E) show DBA staining missing from terminal
epithelial tips (white arrows). Double staining: FITC-DBA (B, E) and
TRITC-anti calbindin D28k (C, F). Merged confocal images (A, D).
UB: ureteric bud, MM: metanephric mesenchyme. Scale bars =100 pm.
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5.3 Are tips different from stalks in other ways?
The previous two chapters have shown that during branching the ureteric bud
tips display specializations such as increased local cell proliferation and special
cytoskeletal rearrangement. The results of the previous section also suggest that
they differ in respect to glycoconjugate expression as revealed by the lack of
DBA binding in the ampullary tips. They also show that subsequent to tip
amputation at the T-shape stage, the stalks have the ability to form new tips. The
question addressed here is whether the ureteric bud tips differ from the stalks at
the molecular level, which is examined by means of differential display PCR on
the early T-shape stage ureteric epithelium.
Differential display is a powerful molecular tool which permits the identification
and subsequent isolation of transcripts differentially expressed between
undifferentiated and differentiated cells or in one tissue at different
developmental stages (Liang and Pardee, 1992; Miele et al., 1998). In a
differential display (figure 5.5), each RNA sample is first reverse transcribed
with an anchored oligo(dT) primer that is modified at the 3'-end (two extra bases
are included) to ensure that it anneals at the start of the poly(A) tail of mRNA
rather than non specifically within the poly(A) tail. The objective is to obtain a
tag of a few hundred bases, which is sufficiently long to uniquely identify a
mRNA but short enough to be separated from others by size (Liang and Pardee,
1997). Polyacrylamide gel electrophoresis can separate DNA molecules that
differ in a range of 1 to 500 bp. In order to amplify fragments of each cDNA
within 500 bp of the mRNA poly(A) tail, short arbitrary 5' primers of 10
nucleotides in length are used (Liang and Pardee, 1992). Incorporation of a
radiolabeled nucleotide into the display reactions allows the resulting PCR
products to be visualized by autoradiography following polyacrylamide
electrophoresis (Miele et al., 1998). For differential display, generally a final
polyacrylamide concentration of 6% is considered appropriate with an effective



















HL Denaturing polyacrylamide gel
RNA sample:
Negative electrode (-)
Positive electrode ( +-)
Figure 5.5 : Schematic representation of differential
display
(From Liang and Pardee, 1997)
156
procedure allows amplification of an mRNA subpopulation without knowledge
of sequence information.
During kidney development, the mesenchymal to epithelial transition (MET) is
accompanied by dramatic changes in gene expression (for reviews see Davies,
1996; Patterson and Dressier, 1994). Differential display has been used to
identify these changes in gene expression between uninduced and induced
mesenchymal cells (Leimeister et al., 1999) as well as to identify genes that are
upregulated during MET either by comparing the gene profiles of E10.5 and E13
metanephroi (Rosenblum and Yager, 1997) or during ex vivo condensation and
tubulogenesis (Plisov et al., 2000).
Here I describe pilot experiments to the hypothesis that in the early stages of
ureteric bud development (El 1.5) tips differ from the stalks in the molecular
level.
5.4 Differential display results
For the experiments, tips and stalks of the T-shape stage ureteric buds of El 1.5
metanephroi were isolated by microdissection and were subjected to gene
expression analysis using the differential display technique (Miele et al., 1998).
Approximately 2 pg of total RNA (estimated from the intensity of ethidium
bromide staining) was prepared from 20 isolated ureteric bud tips and 20 stalks,
and three different anchor oligo-dT-containing primers were used to produce
total cDNA for differential display analysis. Amplified fragments were separated
by high-resolution electophoresis. Most of the amplified cDNA fragments
appeared in both tracks that is did not differ from the tips and stalks. However
few differentially displayed cDNA bands were found - some of these were
specific to tips, and others were specific to stalks, (figure 5.6). Figure 5.6B
shows the presence of differentially expressed cDNA bands both in the stalk and
the tip.
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Anchor 1 Anchor 2 Anchor 3
Figure 5.6: Differential gene
expression between tips and
stems
(A) Differential display gel comparing
mRNA from tips and stalks of El 1.5
ureteric buds using (dT)12VG (anchor 1),
(dT)12VA (anchor 2), (dT)12VC (anchor
3) 3' primers with four random 5'
primers (PI, P2, P3 and P4), (B) is an
enlarged version of the marked area of
(A) showing the presence of a
differential cDNA band in the tip (short
arrow) and a differential cDNA band in
the stalk (long dashed arrow). T: tip, S:
stalk




The results presented here are a preliminary attempt to identify differentially
expressed genes in the ureteric bud epithelium at the early stages of branching
morphogenesis. Even though the sequences of the differential cDNA bands are
not known yet (because the samples were physically destroyed by a colleague in
error), this pilot study suggests that there are differences in gene expression
between tips and stalks in the ureteric bud epithelium at the initial stages of
branching morphogenesis. The stalk-specific bands might have been expected
from known directions of differentiation (as collecting duct cells mature) but tip
specific genes may be novel.
These pilot experiments form the foundation for further analytical work that can
identify the genes involved. This would involve the excision of the differentially
expressed transcripts from the dried gel, cDNA recovery, PCR amplification for
single-stranded conformation polymorphism (SSCP) analysis in order to isolate
with confidence the precise differential bands (Miele et al., 1998). Following
excision of the differential bands, cDNA recovery and PCR re-amplification
using the original primer combination, the fragments will be sequenced for
identification. In situ hybridization will reveal whether the gene in question is
expressed in the epithelium or the surrounding mesenchyme, and will confirm
differential expression in either the tip or the stalk.
These experiments could not be pursued further in the present thesis due to this
project's time limitations that did not allow the complete experiment to be
restarted, following loss of the samples mentioned above.
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5.5 Discussion
5.5.1 Branching correlates with lack of DBA binding from the tips
During ureteric bud branching morphogenesis, the developing epithelium
induces the formation of nephrons and determines the architecture of the kidney.
The nephrons are formed at the terminal tips of the developing ureteric
epithelium, the ampullae, suggesting an important role for this region of the
epithelium. This leads to the hypothesis that the ampullary UB tip might show
differences and specializations throughout its development, specializations that
are important for the branching pattern and eventually the nephron induction.
The two previous chapters have shown that tips differ from stalks in respect to
proliferation and cytoskeletal organization; this chapter shows that they also
differ in respect to glycoconjugate and gene expression.
A lack of DBA binding from the ureteric ampullary tips is observed in El 1.5
murine embryonic kidneys cultured for 24 hours and persists at least until 72
hours (figure 5.1) whereas there is strong binding of DBA in the basement
membranes of the stalks. This is in accordance with a previous finding in
embryonic rat ureteric bud where at Er12.5 DBA staining is excluded from the
terminal tip (Herzlinger et al., 1993). Further evidence comes from the neonatal
rabbit kidney, which since it completes its development within 3-5 weeks after
birth, at the time of birth the collecting duct system continues to develop (Kloth
et al., 1998). In the neonatal rabbit kidney, fully embryonic collecting duct
ampullae are found in the outer cortex and more mature tissue is found in the
midcortical and medullary regions (Kloth et al., 1998). A recent lectin
histochemical study revealed a complete lack of DBA labeling from the
ampullary tip of the neonatal rabbit kidney (Schumacher et al., 2002).
The identity of the glycoconjugate that Dolichos Biflorus agglutinin recognizes is
currently unknown. Recently, a first attempt to identify the glycoconjugate that
DBA recognizes showed that it probably belongs to a group of
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glycosaminoglycans (Schumacher et al., 2002). If this turns out to be the case, it
is possible that the DBA-binding glycoconjugate is directly involved in
branching morphogenesis as removal of all glycosaminoglycans blocks ureteric
bud branching (Davies et al., 1995; plus all chlorate data in this thesis). Lectin
histochemistry studies have shown that DBA is associated with cell
differentiation as it recognizes postmitotic differentiating epidermal cells
(Hrdlickova-Cela et al., 2001) and it binds specifically fully differentiated
trophoblast cells (Nakano et al., 2002). It is possible therefore that the cells at the
ureteric bud stalks that show DBA staining are entering a differentiating stage.
In order to establish whether this specialization at the terminal tip of the ureteric
bud is a special feature of the actively growing epithelium, the effects of
exogenous GDNF (as a branching promoter) or a function-blocking antibody to
GDNF (as a branching inhibitor) on DBA binding were examined. The enlarged
GDNF-treated tips retained their "tip"-phenotype and lacked DBA reactivity, as
did the ectopic-buds emerging from the stalk. The latter finding is surprising as
the "new" outgrowths (ectopic) emerge from an area that does not normally give
rise to new tips and where the differentiation process has started suggesting that
differentiation from tip to stalk is reversible.
Ureteric bud development is arrested when GDNF is blocked with a function
blocking antibody (Davies et al., 1999; Towers et al., 1998). In kidneys treated
with anti-GDNF, DBA staining is present throughout the epithelium with no
specialized compartmentalization. This is also the case in kidneys treated with
chlorate where block of branching is accompanied with loss of specialization at
the tips as seen with the lack ofDBA binding (Davies, unpublished observation).
This suggests that lack of DBA binding correlates with branching activity and
most likely rescue of branching would also result in compartmentalization in the
lectin binding.
Collagen XVIII is a heparan sulphate proteoglycan (Halfter et al., 1998) that in
the developing ureteric bud shows a specific lack of expression from the terminal
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tips (Lin et al., 2001b) similar to the one observed with DBA. Local application
of GDNF is shown to cause loss of the type XVIII collagen expression from the
ureteric bud tips (Lin et al., 2001b). Type XVIII collagen might be a candidate
for DBA, and this could explain the reason why GDNF-enlarged tips were DBA-
negative and why blocking of GDNF shows a uniform DBA reactivity on the
branching-arrested ureteric bud.
5.5.2 Tip generation from stalk
The ability of the stalk to generate new tips (DBA-negative) from locations
where naturally cells form only stalks (DBA-positive) is seen when kidneys are
treated with exogenous GDNF. This is also the case in the generation of new
"tips" from an amputated T-stage ureteric bud. The T-shape UB is able to form
new tips that show a slight disturbed branching pattern orientation but are DBA-
negative suggesting that the differentiation of the stalk is reversible and is able to
generate less mature epithelium (DBA-negative) in order to compensate for the
loss and eventually resume the "right" number of terminal ampullae for efficient
nephron formation. Also there is the possibility that stalks might have the ability
to form tips from any part of them. However as soon as new tips are formed they
might exert a negative signal to the neighbouring stalk cells that prevent them
from forming more tips in a way of controlling their emergence to the most
efficient number or space orientation and thus establishing the architecture of the
developing ureteric bud tree (which allows enough space for "correct" nephron
number).
5.5.3 Differential gene expression
Up to date, several genes have identified to show spatial expression in the
ureteric bud such as the c-ret and c-ros protooncogenes and members of the Wnt
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family (Carroll and McMahon, 2000; Kispert et al., 1996; Pachnis et al., 1993).
The protooncogenes c-ret and c-ros are reported to be expressed at the distal ends
of the ureteric bud branches. More specifically, c-ret expression is restricted at
the ureteric bud tips at E13.5-E17.5 metanephroi (Pachnis et al., 1993), however
at the earlier stage of El 1.5 it is expressed throughout the ureteric bud epithelium
(Fisher et al., 2001). Ros shows a similar expression pattern at the El 1.5 ureteric
bud epithelium (Fisher et al., 2001; Kanwar et al., 1995). Another gene that is
expressed at the branches of the El2.5 ureteric bud epithelium is Sox9 (Kent et
al., 1996) and is used as a marker of the ureteric bud tips (Lin et al., 2001a;
Pepicelli et al., 1997).
The Wnt gene family encode secreted glycoproteins that regulate key
developmental processes including kidney development (for reviews see Carroll
and McMahon, 2000; Vainio et al., 1999; Vainio and Uusitalo, 2000). In the
developing ureteric bud members of the Wnt family reveal a sequential and non-
overlaping expression (Vainio et al., 1999). Wnt-6 and Wnt-11 are both
expressed at the ureteric bud tips (Lin et al., 2001a). Wnt-11 expression is
confined to the tips of the ureteric bud from as early as El 1.5 and continues to be
expressed at the tips of the newly formed branches of the growing ureteric bud
tree (Kispert et al., 1996). Wnt-7b expression is detected in the ureteric bud
epithelium and it is confined to the stalks being excluded completely from the tip
area where Wnt-11 is expressed (Kispert et al., 1996; Vainio et al., 1999).
However, Wnt-7b is first detected in the stalks of the ureteric bud at El3.5
(Vainio et al., 1999).
Extracellular matrix components such as collagen type IV and XVIII are
excluded from the ureteric bud tips. Collagen type IV is present at the proximal
parts of the ureteric bud excluded from the tips (Barasch et al., 1999). Endostatin
a carboxyl-terminal proteolytic cleavage product of collagen XVIII is found to be
prominent at the branch points and the ureteric bud stalk (Karihaloo et al.,
2001a).
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Recent studies have looked at either the gene expression of cells of ureteric bud
origin cultured in monolayers vs. in extracellular matrix (3D tubulogenesis
model) or the global gene expression patterns during the course of kidney
development (Pavlova et al., 1999; Stuart et al., 2001). In the former study,
branching morphogenesis was accompanied with differential expression of
transcription factors with previously described roles in morphogenesis and
downregulation of pro-apoptotic genes accompanied with upregulation of anti-
apoptotic genes (Pavlova et al., 1999). In the same study, a number of genes
were found upregulated in conditions favouring branching morphogenesis such
as c-met, basic fibrobast growth factor (bFGF) receptor and three homeobox
genes, Hox-B5, -B8 and -B9 (Pavlova et al., 1999). In the latter study, gene
expression patterns were examined during kidney organogenesis (Stuart et al.,
2001). In the early embryonic kidney, genes that function in protein synthesis,
DNA replication or structure and RNA synthesis were upregulated consistent
with an actively proliferating tissue (Stuart et al., 2001). The genes for structural
proteins of the extracellular matrix or cytoskeleton were upregulated during
midembryogenesis (Stuart et al., 2001).
To date the evidence of spatiotemporal pattern of gene expression in the ureteric
bud epithelium comes from expression studies. The information obtained herein
is the initial step toward the identification of genes differentially regulated in the
ureteric bud during the emergence of new tips and the establishment of the more
stable stalk epithelium in the course of the formation of the ureteric bud tree.
Further studies are necessary in order to identify which are the genes that are
differentially expressed in the tip of the ureteric bud epithelium. At present only
hypotheses of possible up- or down- regulation of genes can be made. A possible
up-regulation of genes with role in DNA replication would support the
observations described in chapter 3 that the ampullary tips are highly mitogenic
during branching. Another possibility would be the up-regulation of extracellular
proteinases at the tips that would support the observations of other researchers on
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The metanephric kidney has received great attention as it is an excellent model to
study reciprocal epithelial-mesenchymal tissue interactions between the
branching ureteric bud and its surrounding metanephric mesenchyme during
development. To date a wide knowledge exists on the molecular regulation,
secreted molecules and signaling pathways involved in aspects of metanephric
development especially nephrogenesis, whereas the ureteric epithelium
component that itself develops into the collecting duct system has received little
research attention. The formation of an epithelial organ via branching
morphogenesis from a preexisting epithelial tube is currently getting more
interest during organogenesis of a variety of internal organs. The main focus of
my investigation is on the branching morphogenesis of the ureteric bud
epithelium.
The aim of my thesis was to investigate whether the sites of branching activity
namely the ureteric bud tips show specializations in relation to the rest of the
epithelium during development of the collecting duct system.
As an experimental model system, I used the murine metanephric kidney.
Isolated El 1.5 metanephroi develop well in organ culture and undergo
organotypic branching morphogenesis. This allowed manipulation of the
branching morphology by pharmacological agents. The use of
immunohistochemistry in combination with confocal laser scanning microscopy,
which allowed visualization of whole mount organs, provided powerful
techniques for examining with great definition the manipulation effects on the
tubular branching structures during renal organogenesis.
Branching morphogenesis is a result of coordination between mechanical forces
and the processes of cell growth, proliferation, differentiation and death (Hogan,
1999). Hence, the ureteric bud tips were examined for specializations on the
intrinsic mechanisms that drive morphogenesis such as the pattern of cell
proliferation (assessed by BrdU incorporation), cytoskeletal organization
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(localization and inhibition studies) and gene expression (revealed by lectin
histochemistry and differential display).
The results showed that increased localized cell proliferation is a feature of the
actively growing ureteric bud tips in relation to the stalks. When branching
morphogenesis of the ureteric bud was blocked, the cell proliferation at the tips
was greatly reduced suggesting that the newly formed tips are mitogenic. The
ureteric bud during evagination emerges as a single tip from the nephric duct;
BrdU incorporation revealed an increase on cell proliferation at the presumptive
metanephric area suggesting that localized cell proliferation might be the first
sign of ureteric bud. Two known regulators of metanephric development were
examined on their roles on cell proliferation on ureteric bud tips. The branch-
promoting effect of GDNF resulted in an enlargement of the tip area with no
effect on cell proliferation, whereas the branch-inhibiting effect of TGF-P
resulted in a reduction in branching, which was also accompanied with a
reduction in cell proliferation at the tips. Additional work is needed for
identifying further the secreted paracrine factor(s) regulating cell proliferation at
the tips of the branching epithelium and the UB as it evaginates from the
Wollfian duct.
The dramatic shape changes of a developing branching epithelium are a result of
cytoskeletal rearrangement. This is also the case during branching activity of the
ureteric bud epithelium, as revealed with localization and inhibition of actin
filaments and myosin. Phalloidin staining showed a strong expression of actin
microfilaments at the ureteric bud tips during branching activity which was lost
when branching was inhibited. Two widely used drugs, cytochalasin D and
butanedione monoxime for inhibition of actin and myosin respectively, resulted
in reduced ureteric bud branching, confirming that acto-myosin contractility is
necessary for branching activity. Mild pharmacological inhibition of actin
polymerization with cytochalasin D resulted in disrupted epithelial tip
morphology with altered cell junctions as shown with E-cadherin
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immunostaining. Further work will elucidate the signaling pathways regulating
the cytoskeletal rearrangement in the branching epithelium, as well as the role
and turnover of cell junction proteins in the ureteric bud tips.
Lectin histochemistry studies revealed a difference in expression of lectin
binding glycoconjugates at the ureteric bud tips. The Dolichos Biflorus
agglutinin (DBA), which is widely used as collecting duct marker, showed lack
of binding to the ureteric bud tips. This specialization persisted throughout
branching morphogenesis at the culture times studied and was lost when
branching was blocked. Organ recombination studies showed that the ureteric
bud stalks are able to form new tips when one UB tip is amputated from the T-
shape stage ureteric bud. These newly formed tips regain their tip state as
revealed with the lack of DBA binding. The differential expression of lectin
binding glycoconjugates, along the actively growing epithelium, suggested the
possibility that other genes than the currently known (such as Wnt-11) might be
expressed in the El 1.5 ureteric bud tip epithelium that might be identified as tip
(or even stalk) markers. This hypothesis was tested in a pilot study using
differential display. The preliminary results showed the presence of differentially
expressed bands between the UB tips and stalks at the early stages of branching
morphogenesis. Further studies are required on identifying the differential genes
expressed between the two epithelial compartments, their expression and their
role on UB development.
The key conclusion of my work is that several aspects of cell biology of the
ureteric bud tips (proliferation, cytoskeleton, molecular expression) differ from
that of stalks in response to the effects of the surrounding mesenchyme, but only
when the tips are actively growing and branching. One possible limitation of the
approach that I have taken is that due to the reciprocal interactions between the
ureteric epithelium and surrounding metanephric mesenchyme, there is always
the possibility of an indirect effect emanating from the mesenchyme during in
vitro morphogenesis and manipulation. In principle, this limitation could be
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addressed by separating epithelium and mesenchyme, subjecting them to
different experimental treatments (such as transfection of dominant negative
mutants) and recombining them.
The results presented in this thesis link the morphogenetic mechanisms that drive
changes during embryogenesis with the organogenesis of the collecting duct
system. Ureteric bud branching morphogenesis is a process of considerable
interest as it plays a major role in determining the nephron number in the kidney
and hence its functionality. In essence, abnormal or defective ureteric bud
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